Amedeo Smart

Free Medical Literature Service


 

Amedeo

COVID-19

  Free Subscription

Articles published in
N Engl J Med
    September 2022
  1. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Assessing Bivalent Vaccines against Covid-19.
    N Engl J Med. 2022;387:e37.
    >> Share

  2. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Can Vaccines Prevent Transmission of Covid-19?
    N Engl J Med. 2022;387:e30.
    >> Share

  3. THURNER L, Kessel C, Fadle N, Regitz E, et al
    IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination.
    N Engl J Med. 2022 Sep 21. doi: 10.1056/NEJMc2205667.
    >> Share

  4. CHALKIAS S, Harper C, Vrbicky K, Walsh SR, et al
    A Bivalent Omicron-Containing Booster Vaccine against Covid-19.
    N Engl J Med. 2022 Sep 16. doi: 10.1056/NEJMoa2208343.
    >> Share

  5. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Developing Mucosal Immunity to Covid-19.
    N Engl J Med. 2022;387:e29.
    >> Share

  6. HAVERVALL S, Marking U, Svensson J, Greilert-Norin N, et al
    Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection.
    N Engl J Med. 2022 Sep 14. doi: 10.1056/NEJMc2209651.
    >> Share

  7. SHEN X, Chalkias S, Feng J, Chen X, et al
    Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination.
    N Engl J Med. 2022 Sep 9. doi: 10.1056/NEJMc2210648.
    >> Share

  8. SULLIVAN DJ, Gebo KA, Hanley DF
    Convalescent Plasma for Covid-19. Reply.
    N Engl J Med. 2022;387:955-956.
    >> Share

  9. PANETH N
    Convalescent Plasma for Covid-19.
    N Engl J Med. 2022;387:955.
    >> Share

  10. JOYNER MJ, Pirofski LA
    Convalescent Plasma for Covid-19.
    N Engl J Med. 2022;387:955.
    >> Share

  11. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Rolling Out New Covid-19 Vaccines.
    N Engl J Med. 2022;387:e26.
    >> Share

  12. CHARNESS ME, Gupta K, Stack G, Strymish J, et al
    Rebound of SARS-CoV-2 Infection after Nirmatrelvir-Ritonavir Treatment.
    N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2206449.
    >> Share

  13. QU P, Faraone JN, Evans JP, Zheng YM, et al
    Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants.
    N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2210546.
    >> Share

  14. ANDERSON AS, Caubel P, Rusnak JM
    Nirmatrelvir-Ritonavir and Viral Load Rebound in Covid-19.
    N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2205944.
    >> Share

  15. LIN DY, Gu Y, Xu Y, Zeng D, et al
    Effects of Vaccination and Previous Infection on Omicron Infections in Children.
    N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2209371.
    >> Share

  16. DUPONT SC, Galea S
    Science, Competing Values, and Trade-offs in Public Health - The Example of Covid-19 and Masking.
    N Engl J Med. 2022 Sep 3. doi: 10.1056/NEJMp2207670.
    >> Share

  17. RUBIN EJ, Baden LR, Swaminathan S, Morrissey S, et al
    Audio Interview: Covid-19 and the WHO.
    N Engl J Med. 2022;387:e24.
    >> Share

    August 2022
  18. BAROUCH DH
    Covid-19 Vaccines - Immunity, Variants, Boosters.
    N Engl J Med. 2022 Aug 31. doi: 10.1056/NEJMra2206573.
    >> Share

  19. MALATO J, Ribeiro RM, Leite PP, Casaca P, et al
    Risk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants.
    N Engl J Med. 2022 Aug 31. doi: 10.1056/NEJMc2209479.
    >> Share

  20. MACDONALD SM, Berv J
    Losing Contact - Covid-19, Telemedicine, and the Patient-Provider Relationship.
    N Engl J Med. 2022 Aug 27. doi: 10.1056/NEJMp2206471.
    >> Share

  21. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Choosing an Antiviral to Treat Covid-19.
    N Engl J Med. 2022;387:e22.
    >> Share

  22. ARBEL R, Wolff Sagy Y, Hoshen M, Battat E, et al
    Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge.
    N Engl J Med. 2022 Aug 24. doi: 10.1056/NEJMoa2204919.
    >> Share

  23. ABDOOL KARIM SS, Devnarain N
    Time to Stop Using Ineffective Covid-19 Drugs.
    N Engl J Med. 2022;387:654-655.
    >> Share

  24. BRAMANTE CT, Huling JD, Tignanelli CJ, Buse JB, et al
    Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.
    N Engl J Med. 2022;387:599-610.
    >> Share

  25. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Combating Covid-19 Today and Tomorrow.
    N Engl J Med. 2022;387:e17.
    >> Share

  26. JOST TS
    Considering Race and Ethnicity in Covid Risk Assessments - Legal Concerns and Possible Solutions.
    N Engl J Med. 2022;387:481-483.
    >> Share

  27. KOHANE I, Omenn GS
    Understanding Covid Vaccine Efficacy over Time - Bridging a Gap Between Public Health and Health Care.
    N Engl J Med. 2022 Aug 6. doi: 10.1056/NEJMp2201084.
    >> Share

  28. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Updated Covid-19 Vaccines and a Look at Monkeypox.
    N Engl J Med. 2022;387:e16.
    >> Share

  29. TAKASHITA E, Yamayoshi S, Simon V, van Bakel H, et al
    Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants.
    N Engl J Med. 2022;387:468-470.
    >> Share

    July 2022
  30. RUBIN EJ, Baden LR, Currier JS, Morrissey S, et al
    Audio Interview: Reinventing the Research Infrastructure to Address Covid-19.
    N Engl J Med. 2022;387:e13.
    >> Share

  31. RUBIN EJ, Baden LR, Jha A, Morrissey S, et al
    Audio Interview: A Look at the U.S. Government's Covid-19 Strategy.
    N Engl J Med. 2022;387:e11.
    >> Share

  32. TAN SHX, Cook AR, Heng D, Ong B, et al
    Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age.
    N Engl J Med. 2022 Jul 20. doi: 10.1056/NEJMoa2203209.
    >> Share

  33. MAIER HE, Balmaseda A, Saborio S, Ojeda S, et al
    Protection Associated with Previous SARS-CoV-2 Infection in Nicaragua.
    N Engl J Med. 2022 Jul 20. doi: 10.1056/NEJMc2203985.
    >> Share

  34. HAMMOND J, Bao W, Simon-Campos A
    Nirmatrelvir for Nonhospitalized Adults with Covid-19. Reply.
    N Engl J Med. 2022;387.
    >> Share

  35. MORRIS AM, Lee TC
    Nirmatrelvir for Nonhospitalized Adults with Covid-19.
    N Engl J Med. 2022;387.
    >> Share

  36. CHEN BS, Hung CH, Wei JC
    Nirmatrelvir for Nonhospitalized Adults with Covid-19.
    N Engl J Med. 2022;387.
    >> Share

  37. RUBIN EJ, Baden LR, Marks P, Morrissey S, et al
    Audio Interview: Covid-19 Vaccines and the FDA.
    N Engl J Med. 2022;387:e10.
    >> Share

  38. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Designing the Next Covid-19 Vaccine.
    N Engl J Med. 2022;387:e6.
    >> Share

  39. ZHAO X, Zhang R, Qiao S, Wang X, et al
    Omicron SARS-CoV-2 Neutralization from Inactivated and ZF2001 Vaccines.
    N Engl J Med. 2022 Jul 6. doi: 10.1056/NEJMc2206900.
    >> Share

    June 2022
  40. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: How Effective is Covid-19 Vaccination in Children?
    N Engl J Med. 2022;386:e78.
    >> Share

  41. WAXMAN JG, Magen O, Hernan MA
    Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine. Reply.
    N Engl J Med. 2022;387.
    >> Share

  42. TUMMINIA A, Romano M
    Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine.
    N Engl J Med. 2022;387.
    >> Share

  43. COHEN-STAVI CJ, Magen O, Barda N, Yaron S, et al
    BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age.
    N Engl J Med. 2022 Jun 29. doi: 10.1056/NEJMoa2205011.
    >> Share

  44. BOUCAU J, Marino C, Regan J, Uddin R, et al
    Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection.
    N Engl J Med. 2022 Jun 29. doi: 10.1056/NEJMc2202092.
    >> Share

  45. SCHONBORN L, Seck SE, Thiele T, Warkentin TE, et al
    SARS-CoV-2 Infection in Patients with a History of VITT.
    N Engl J Med. 2022 Jun 27. doi: 10.1056/NEJMc2206601.
    >> Share

  46. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Vaccinating Young Children against Covid-19.
    N Engl J Med. 2022;386:e77.
    >> Share

  47. BAR-ON YM, Goldberg Y, Milo R
    Protection by a Fourth Dose of BNT162b2 against Omicron in Israel. Reply.
    N Engl J Med. 2022;386:2441-2442.
    >> Share

  48. WOHL A, Leibowitz R
    Protection by a Fourth Dose of BNT162b2 against Omicron in Israel.
    N Engl J Med. 2022;386:2441.
    >> Share

  49. DESILVA M, Haapala J, Vazquez-Benitez G, Vesco KK, et al
    Evaluation of Acute Adverse Events after Covid-19 Vaccination during Pregnancy.
    N Engl J Med. 2022 Jun 22. doi: 10.1056/NEJMc2205276.
    >> Share

  50. HALASA NB, Olson SM, Staat MA, Newhams MM, et al
    Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants.
    N Engl J Med. 2022 Jun 22. doi: 10.1056/NEJMoa2204399.
    >> Share

  51. RASMUSSEN SA, Jamieson DJ
    Covid-19 Vaccination during Pregnancy - Two for the Price of One.
    N Engl J Med. 2022 Jun 22. doi: 10.1056/NEJMe2206730.
    >> Share

  52. HACHMANN NP, Miller J, Collier AY, Ventura JD, et al
    Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5.
    N Engl J Med. 2022 Jun 22. doi: 10.1056/NEJMc2206576.
    >> Share

  53. RUBIN EJ, Baden LR, Abraham J, Morrissey S, et al
    Audio Interview: Viral Evolution and the Future of Monoclonal Antibodies.
    N Engl J Med. 2022;386:e75.
    >> Share

  54. PRICE AM, Olson SM, Patel MM
    BNT162b2 Protection against the Omicron Variant in Children and Adolescents. Reply.
    N Engl J Med. 2022;386:2346.
    >> Share

  55. ZENG G
    BNT162b2 Protection against the Omicron Variant in Children and Adolescents.
    N Engl J Med. 2022;386:2345-2346.
    >> Share

  56. LEUCHTER RK, Jackson NJ, Mafi JN, Sarkisian CA, et al
    Association between Covid-19 Vaccination and Influenza Vaccination Rates.
    N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMc2204560.
    >> Share

  57. QU P, Faraone J, Evans JP, Zou X, et al
    Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants.
    N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMc2206725.
    >> Share

  58. HOPKINS S, Hall V, Klenerman P
    Protection against SARS-CoV-2 after Vaccination and Previous Infection. Reply.
    N Engl J Med. 2022;386.
    >> Share

  59. MATUCHANSKY C
    Protection against SARS-CoV-2 after Vaccination and Previous Infection.
    N Engl J Med. 2022;386.
    >> Share

  60. ALTARAWNEH HN, Chemaitelly H, Ayoub HH, Tang P, et al
    Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections.
    N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMoa2203965.
    >> Share

  61. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Protecting the Immunocompromised from Covid-19.
    N Engl J Med. 2022;386:e71.
    >> Share

  62. ABRAHAM J
    Monoclonal Antibodies with Extended Half-Life to Prevent Covid-19.
    N Engl J Med. 2022;386:2236-2238.
    >> Share

  63. JOLOBE OMP
    Protection Due to Previous SARS-CoV-2 Infection.
    N Engl J Med. 2022;386.
    >> Share

  64. SCHERER EM, Babiker A, Adelman MW, Allman B, et al
    SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients.
    N Engl J Med. 2022 Jun 8. doi: 10.1056/NEJMc2202861.
    >> Share

  65. RUBIN EJ, Baden LR, Moore PL, Morrissey S, et al
    Audio Interview: Dissecting the Host Response to SARS-CoV-2.
    N Engl J Med. 2022;386:e69.
    >> Share

    May 2022
  66. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Waning Immunity against Covid-19.
    N Engl J Med. 2022;386:e64.
    >> Share

  67. ACCORSI EK, Britton A, Shang N, Fleming-Dutra KE, et al
    Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron.
    N Engl J Med. 2022 May 25. doi: 10.1056/NEJMc2203165.
    >> Share

  68. GOLDBERG Y, Mandel M, Bar-On YM, Bodenheimer O, et al
    Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2.
    N Engl J Med. 2022 May 25. doi: 10.1056/NEJMoa2118946.
    >> Share

  69. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: What to Make of Covid-19 Hot Spots.
    N Engl J Med. 2022;386:e63.
    >> Share

  70. BROWN PE, Fu SH, Bansal A, Newcombe L, et al
    Omicron BA.1/1.1 SARS-CoV-2 Infection among Vaccinated Canadian Adults.
    N Engl J Med. 2022 May 18. doi: 10.1056/NEJMc2202879.
    >> Share

  71. EVANS JP, Qu P, Zeng C, Zheng YM, et al
    Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants.
    N Engl J Med. 2022 May 18. doi: 10.1056/NEJMc2205019.
    >> Share

  72. RUBIN EJ, Baden LR, Lipsitch M, Morrissey S, et al
    Audio Interview: Forecasting the Future of Covid.
    N Engl J Med. 2022;386:e58.
    >> Share

  73. CREECH CB, Anderson E, Berthaud V, Yildirim I, et al
    Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age.
    N Engl J Med. 2022 May 11. doi: 10.1056/NEJMoa2203315.
    >> Share

  74. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Do We Need New Covid-19 Vaccines?
    N Engl J Med. 2022;386:e52.
    >> Share

  75. ESTCOURT L, Callum J
    Convalescent Plasma for Covid-19 - Making Sense of the Inconsistencies.
    N Engl J Med. 2022;386:1753-1754.
    >> Share

  76. PERSAD G, Pandya A
    A Comprehensive Covid-19 Response - The Need for Economic Evaluation.
    N Engl J Med. 2022 May 4. doi: 10.1056/NEJMp2202828.
    >> Share

  77. HAGER KJ, Perez Marc G, Gobeil P, Diaz RS, et al
    Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine.
    N Engl J Med. 2022 May 4. doi: 10.1056/NEJMoa2201300.
    >> Share

  78. DAI L, Gao L, Tao L, Hadinegoro SR, et al
    Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults.
    N Engl J Med. 2022 May 4. doi: 10.1056/NEJMoa2202261.
    >> Share

  79. NOHYNEK H, Wilder-Smith A
    Does the World Still Need New Covid-19 Vaccines?
    N Engl J Med. 2022 May 4. doi: 10.1056/NEJMe2204695.
    >> Share

  80. GRAY G, Collie S, Goga A, Garrett N, et al
    Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa.
    N Engl J Med. 2022 May 4. doi: 10.1056/NEJMc2202061.
    >> Share

    April 2022
  81. RUBIN EJ, Baden LR, Marrazzo JM, Morrissey S, et al
    Audio Interview: Communicating Covid-19 Science.
    N Engl J Med. 2022;386:e53.
    >> Share

  82. RUBIN EJ, Baden LR, Inglefinger JR, Morrissey S, et al
    Audio Interview: The Effects of Covid-19 on Children.
    N Engl J Med. 2022;386:e51.
    >> Share

  83. BHATTACHARYYA RP, Hanage WP
    Intrinsic Severity of the SARS-CoV-2 Omicron Variant. Reply.
    N Engl J Med. 2022 Apr 20. pii: 10.1056/NEJMc2203679.
    >> Share

  84. SHAFER SL
    Intrinsic Severity of the SARS-CoV-2 Omicron Variant.
    N Engl J Med. 2022 Apr 20. pii: 10.1056/NEJMc2203679.
    >> Share

  85. LEVIN MJ, Ustianowski A, De Wit S, Launay O, et al
    Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19.
    N Engl J Med. 2022 Apr 20. doi: 10.1056/NEJMoa2116620.
    >> Share

  86. OFFIT PA
    Covid-19 Boosters - Where from Here?
    N Engl J Med. 2022 Apr 13. doi: 10.1056/NEJMe2203329.
    >> Share

  87. MAGEN O, Waxman JG, Makov-Assif M, Vered R, et al
    Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.
    N Engl J Med. 2022 Apr 13. doi: 10.1056/NEJMoa2201688.
    >> Share

  88. DRAIN PK
    Rapid Diagnostic Testing for SARS-CoV-2. Reply.
    N Engl J Med. 2022;386.
    >> Share

  89. BOGATY P
    Rapid Diagnostic Testing for SARS-CoV-2.
    N Engl J Med. 2022;386.
    >> Share

  90. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Do We Need a Fourth Dose of Covid Vaccine?
    N Engl J Med. 2022;386:e45.
    >> Share

  91. MOORE PL, Baden LR
    Omicron - Decoupling Infection from Severe Disease.
    N Engl J Med. 2022;386:1361-1362.
    >> Share

  92. HORWITZ JR, Wiley LF
    Not Ready for the End Game - Why Ending Federal Covid-19 Emergency Declarations Will Harm Access to Care.
    N Engl J Med. 2022 Apr 6. doi: 10.1056/NEJMp2203468.
    >> Share

  93. YOON SK, Hegmann KT, Thiese MS, Burgess JL, et al
    Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers.
    N Engl J Med. 2022 Apr 6. doi: 10.1056/NEJMc2201821.
    >> Share

  94. LEE KC, Morgan AU, Chaiyachati KH, Asch DA, et al
    Pulse Oximetry for Monitoring Patients with Covid-19 at Home - A Pragmatic, Randomized Trial.
    N Engl J Med. 2022 Apr 6. doi: 10.1056/NEJMc2201541.
    >> Share

  95. BAR-ON YM, Goldberg Y, Mandel M, Bodenheimer O, et al
    Protection by a Fourth Dose of BNT162b2 against Omicron in Israel.
    N Engl J Med. 2022 Apr 5. doi: 10.1056/NEJMoa2201570.
    >> Share

    March 2022
  96. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Effectiveness of Covid-19 Vaccination in Children.
    N Engl J Med. 2022;386:e39.
    >> Share

  97. KLEIN NP
    Added Benefit of Covid-19 Vaccination after Previous Infection.
    N Engl J Med. 2022;386:1278-1279.
    >> Share

  98. REIS G, Silva EASM, Silva DCM, Thabane L, et al
    Effect of Early Treatment with Ivermectin among Patients with Covid-19.
    N Engl J Med. 2022 Mar 30. doi: 10.1056/NEJMoa2115869.
    >> Share

  99. PRICE AM, Olson SM, Newhams MM, Halasa NB, et al
    BNT162b2 Protection against the Omicron Variant in Children and Adolescents.
    N Engl J Med. 2022 Mar 30. doi: 10.1056/NEJMoa2202826.
    >> Share

  100. SULLIVAN DJ, Gebo KA, Shoham S, Bloch EM, et al
    Early Outpatient Treatment for Covid-19 with Convalescent Plasma.
    N Engl J Med. 2022 Mar 30. doi: 10.1056/NEJMoa2119657.
    >> Share

  101. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19: Why We Publish What We Do.
    N Engl J Med. 2022;386:e38.
    >> Share

  102. VYAS JM, Castle AC, Bourgouin PP, Turbett SE, et al
    Case 9-2022: A 56-Year-Old Woman with Fever, Myalgias, Diarrhea, and Cough.
    N Engl J Med. 2022;386:1166-1174.
    >> Share

  103. ROSSLER A, Knabl L, von Laer D, Kimpel J, et al
    Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection.
    N Engl J Med. 2022 Mar 23. doi: 10.1056/NEJMc2201607.
    >> Share

  104. MOREIRA ED JR, Kitchin N, Xu X, Dychter SS, et al
    Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.
    N Engl J Med. 2022 Mar 23. doi: 10.1056/NEJMoa2200674.
    >> Share

  105. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Can We Make More Effective Covid-19 Vaccines?
    N Engl J Med. 2022;386:e36.
    >> Share

  106. REGEV-YOCHAY G, Gonen T, Gilboa M, Mandelboim M, et al
    Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron.
    N Engl J Med. 2022 Mar 16. doi: 10.1056/NEJMc2202542.
    >> Share

  107. SHAPIRO AE, Gupta A
    Early Treatment with Sotrovimab for Covid-19. Reply.
    N Engl J Med. 2022 Mar 16. pii: 10.1056/NEJMc2201606.
    >> Share

  108. FUJIWARA Y
    Early Treatment with Sotrovimab for Covid-19.
    N Engl J Med. 2022 Mar 16. pii: 10.1056/NEJMc2201606.
    >> Share

  109. ORIGUEN J, Caro-Teller JM, Lopez-Medrano F
    Early Treatment with Sotrovimab for Covid-19.
    N Engl J Med. 2022 Mar 16. pii: 10.1056/NEJMc2201606.
    >> Share

  110. HATZL S, Krause R, Schilcher G
    Early Treatment with Sotrovimab for Covid-19.
    N Engl J Med. 2022 Mar 16. pii: 10.1056/NEJMc2201606.
    >> Share

  111. YU J, Collier AY, Rowe M, Mardas F, et al
    Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants.
    N Engl J Med. 2022 Mar 16. doi: 10.1056/NEJMc2201849.
    >> Share

  112. DE ANDA C, Johnson MG, Pedley A
    Molnupiravir for Covid-19 in Nonhospitalized Patients. Reply.
    N Engl J Med. 2022;386.
    >> Share

  113. ROBERFROID D, Jespers V, Hulstaert F
    Molnupiravir for Covid-19 in Nonhospitalized Patients.
    N Engl J Med. 2022;386.
    >> Share

  114. LEVENSTEIN S
    Molnupiravir for Covid-19 in Nonhospitalized Patients.
    N Engl J Med. 2022;386.
    >> Share

  115. SELVI-SABATER P, Abellon-Ruiz J
    Molnupiravir for Covid-19 in Nonhospitalized Patients.
    N Engl J Med. 2022;386.
    >> Share

  116. THORLUND K, Sheldrick K, Mills E
    Molnupiravir for Covid-19 in Nonhospitalized Patients.
    N Engl J Med. 2022;386.
    >> Share

  117. RUBIN EJ, Baden LR, Hunter D, Morrissey S, et al
    Audio Interview: Making Covid-19 Vaccines Available around the World.
    N Engl J Med. 2022;386:e31.
    >> Share

  118. TAKASHITA E, Kinoshita N, Yamayoshi S, Sakai-Tagawa Y, et al
    Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2.
    N Engl J Med. 2022 Mar 9. doi: 10.1056/NEJMc2201933.
    >> Share

  119. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, AlMukdad S, et al
    Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar.
    N Engl J Med. 2022 Mar 9. doi: 10.1056/NEJMoa2200797.
    >> Share

  120. ROCKETT R, Basile K, Maddocks S, Fong W, et al
    Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use.
    N Engl J Med. 2022 Mar 9. doi: 10.1056/NEJMc2120219.
    >> Share

  121. MONTO AS
    The Future of SARS-CoV-2 Vaccination. Reply.
    N Engl J Med. 2022;386:899-900.
    >> Share

  122. BACHMANN MF, Mohsen MO, Speiser DE
    The Future of SARS-CoV-2 Vaccination.
    N Engl J Med. 2022;386:899.
    >> Share

  123. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Using Our Covid-19 Experience to Develop Vaccines More Quickly.
    N Engl J Med. 2022;386:e29.
    >> Share

  124. GEE JE, Bower WA, Kunkel A, Petras J, et al
    Multistate Outbreak of Melioidosis Associated with Imported Aromatherapy Spray.
    N Engl J Med. 2022;386:861-868.
    >> Share

  125. MELLO MM, Parmet WE
    U.S. Public Health Law - Foundations and Emerging Shifts.
    N Engl J Med. 2022;386:805-808.
    >> Share

  126. ZHAO X, Li D, Ruan W, Chen Z, et al
    Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant.
    N Engl J Med. 2022;386:894-896.
    >> Share

  127. WALTER EB, Talaat KR, Gurtman A
    More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply.
    N Engl J Med. 2022;386.
    >> Share

  128. LEIBOWITZ R, Schurr E, Hirsch O
    More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
    N Engl J Med. 2022;386.
    >> Share

  129. TAYTARD J, Prevost B, Corvol H
    More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
    N Engl J Med. 2022;386.
    >> Share

  130. ANDREWS N, Stowe J, Kirsebom F, Toffa S, et al
    Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.
    N Engl J Med. 2022 Mar 2. doi: 10.1056/NEJMoa2119451.
    >> Share

    February 2022
  131. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Understanding the Omicron Variant of SARS-CoV-2.
    N Engl J Med. 2022;386:e27.
    >> Share

  132. HUNTER DJ, Abdool Karim SS, Baden LR, Farrar JJ, et al
    Addressing Vaccine Inequity - Covid-19 Vaccines as a Global Public Good.
    N Engl J Med. 2022 Feb 23. doi: 10.1056/NEJMe2202547.
    >> Share

  133. MADHI SA, Kwatra G, Myers JE, Jassat W, et al
    Population Immunity and Covid-19 Severity with Omicron Variant in South Africa.
    N Engl J Med. 2022 Feb 23. doi: 10.1056/NEJMoa2119658.
    >> Share

  134. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New Antiviral against Covid-19.
    N Engl J Med. 2022;386:e25.
    >> Share

  135. FLEISHER LA, Schreiber M, Cardo D, Srinivasan A, et al
    Health Care Safety during the Pandemic and Beyond - Building a System That Ensures Resilience.
    N Engl J Med. 2022;386:609-611.
    >> Share

  136. HAMMERMAN A, Sergienko R, Friger M, Beckenstein T, et al
    Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19.
    N Engl J Med. 2022 Feb 16. doi: 10.1056/NEJMoa2119497.
    >> Share

  137. HAMMOND J, Leister-Tebbe H, Gardner A, Abreu P, et al
    Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19.
    N Engl J Med. 2022 Feb 16. doi: 10.1056/NEJMoa2118542.
    >> Share

  138. GOTTLIEB RL, Juneja K, Hill JA
    Outpatient Remdesivir to Prevent Progression to Severe Covid-19. Reply.
    N Engl J Med. 2022 Feb 16. pii: 10.1056/NEJMc2200591.
    >> Share

  139. ENNEZAT PV
    Outpatient Remdesivir to Prevent Progression to Severe Covid-19.
    N Engl J Med. 2022 Feb 16. pii: 10.1056/NEJMc2200591.
    >> Share

  140. HALL V, Foulkes S, Insalata F, Kirwan P, et al
    Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection.
    N Engl J Med. 2022 Feb 16. doi: 10.1056/NEJMoa2118691.
    >> Share

  141. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19 as an Endemic Disease.
    N Engl J Med. 2022;386:e21.
    >> Share

  142. SADOFF J, Gray G, Vandebosch A, Cardenas V, et al
    Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S.
    N Engl J Med. 2022 Feb 9. doi: 10.1056/NEJMoa2117608.
    >> Share

  143. ALTARAWNEH HN, Chemaitelly H, Hasan MR, Ayoub HH, et al
    Protection against the Omicron Variant from Previous SARS-CoV-2 Infection.
    N Engl J Med. 2022 Feb 9. doi: 10.1056/NEJMc2200133.
    >> Share

  144. ARBEL R, Sergienko R, Hammerman A
    BNT162b2 Vaccine Booster and Covid-19 Mortality. Reply.
    N Engl J Med. 2022 Feb 9. pii: 10.1056/NEJMc2120044.
    >> Share

  145. PILZ S
    BNT162b2 Vaccine Booster and Covid-19 Mortality.
    N Engl J Med. 2022 Feb 9. pii: 10.1056/NEJMc2120044.
    >> Share

  146. ROHBAN T
    BNT162b2 Vaccine Booster and Covid-19 Mortality.
    N Engl J Med. 2022 Feb 9. pii: 10.1056/NEJMc2120044.
    >> Share

  147. MAYR FB, Talisa VB, Shaikh O, Yende S, et al
    Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans.
    N Engl J Med. 2022 Feb 9. doi: 10.1056/NEJMc2200415.
    >> Share


  148. Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.
    N Engl J Med. 2022;386:500.
    >> Share

  149. RUBIN EJ, Baden LR, Rosen CJ, Morrissey S, et al
    Audio Interview: Studying Long Covid.
    N Engl J Med. 2022;386:e20.
    >> Share

  150. BRAGA NETO MB, Badley AD, Parikh SA, Graham RP, et al
    Calm before the Storm.
    N Engl J Med. 2022;386:479-485.
    >> Share

  151. MURPHY WJ, Longo DL
    Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination. Reply.
    N Engl J Med. 2022 Feb 2. pii: 10.1056/NEJMc2119443.
    >> Share

  152. HARVILLE TO, Arthur JM
    Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination.
    N Engl J Med. 2022 Feb 2. pii: 10.1056/NEJMc2119443.
    >> Share

  153. DE MARIA A
    Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination.
    N Engl J Med. 2022 Feb 2. pii: 10.1056/NEJMc2119443.
    >> Share

  154. BHATTACHARYYA RP, Hanage WP
    Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant.
    N Engl J Med. 2022 Feb 2. doi: 10.1056/NEJMp2119682.
    >> Share

    January 2022
  155. RUBIN EJ, Baden LR, Barocas JA, Morrissey S, et al
    Audio Interview: Addressing the Omicron Variant of SARS-CoV-2.
    N Engl J Med. 2022;386:e16.
    >> Share

  156. TAKASHITA E, Kinoshita N, Yamayoshi S, Sakai-Tagawa Y, et al
    Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant.
    N Engl J Med. 2022 Jan 26. doi: 10.1056/NEJMc2119407.
    >> Share

  157. ROACH A, Chikwe J, Catarino P, Rampolla R, et al
    Lung Transplantation for Covid-19-Related Respiratory Failure in the United States.
    N Engl J Med. 2022 Jan 26. doi: 10.1056/NEJMc2117024.
    >> Share

  158. PAJON R, Doria-Rose NA, Shen X, Schmidt SD, et al
    SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination.
    N Engl J Med. 2022 Jan 26. doi: 10.1056/NEJMc2119912.
    >> Share

  159. ABU-RADDAD LJ, Chemaitelly H, Bertollini R
    Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar.
    N Engl J Med. 2022 Jan 26. doi: 10.1056/NEJMc2119432.
    >> Share

  160. ATMAR RL, Lyke KE, Deming ME, Jackson LA, et al
    Homologous and Heterologous Covid-19 Booster Vaccinations.
    N Engl J Med. 2022 Jan 26. doi: 10.1056/NEJMoa2116414.
    >> Share

  161. MEVORACH D, Anis E, Cedar N, Hasin T, et al
    Myocarditis after BNT162b2 Vaccination in Israeli Adolescents.
    N Engl J Med. 2022 Jan 26. doi: 10.1056/NEJMc2116999.
    >> Share

  162. RUBIN EJ, Baden LR, Fineberg HV, Morrissey S, et al
    Audio Interview: Crushing the Covid-19 Curve.
    N Engl J Med. 2022;386:e13.
    >> Share

  163. SABLEROLLES RSG, Rietdijk WJR, Goorhuis A, Postma DF, et al
    Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming.
    N Engl J Med. 2022 Jan 19. doi: 10.1056/NEJMoa2116747.
    >> Share

  164. WALTER EB, Talaat KR, Gurtman A
    BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply.
    N Engl J Med. 2022;386.
    >> Share

  165. MINTZKER Y
    BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
    N Engl J Med. 2022;386.
    >> Share

  166. FANG SF, Liu N, Du HW
    BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
    N Engl J Med. 2022;386.
    >> Share

  167. ABU-RADDAD LJ, Chemaitelly H, Bertollini R
    Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar.
    N Engl J Med. 2022 Jan 19. doi: 10.1056/NEJMc2117933.
    >> Share

  168. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19 Takeaways at Podcast 100.
    N Engl J Med. 2022;386:e11.
    >> Share

  169. WEINSTEIN DF
    Reengineering GME in a Pandemic - Looking Back, and Forward.
    N Engl J Med. 2022;386:97.
    >> Share

  170. ROSSLER A, Riepler L, Bante D, von Laer D, et al
    SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons.
    N Engl J Med. 2022 Jan 12. doi: 10.1056/NEJMc2119236.
    >> Share

  171. OLSON SM, Newhams MM, Halasa NB, Price AM, et al
    Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents.
    N Engl J Med. 2022 Jan 12. doi: 10.1056/NEJMoa2117995.
    >> Share

  172. ANDREWS N, Tessier E, Stowe J, Gower C, et al
    Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines.
    N Engl J Med. 2022 Jan 12. doi: 10.1056/NEJMoa2115481.
    >> Share

  173. EDWARDS KM
    Sparing of Severe Covid-19 in Vaccinated Adolescents.
    N Engl J Med. 2022 Jan 12. doi: 10.1056/NEJMe2118471.
    >> Share

  174. LIN DY, Gu Y, Wheeler B, Young H, et al
    Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina.
    N Engl J Med. 2022 Jan 12. doi: 10.1056/NEJMoa2117128.
    >> Share

  175. DRAIN PK
    Rapid Diagnostic Testing for SARS-CoV-2.
    N Engl J Med. 2022 Jan 7. doi: 10.1056/NEJMcp2117115.
    >> Share

  176. RUBIN EJ, Baden LR, Drosten C, Morrissey S, et al
    Audio Interview: Covid-19 - The Outlook in Europe.
    N Engl J Med. 2022;386:e9.
    >> Share

  177. EYRE DW, Taylor D, Purver M, Chapman D, et al
    Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants.
    N Engl J Med. 2022 Jan 5. doi: 10.1056/NEJMoa2116597.
    >> Share

  178. GONEN T, Lustig Y, Regev-Yochay G
    Covid-19 Infections in Vaccinated Health Care Workers. Reply.
    N Engl J Med. 2022;386.
    >> Share

  179. RASTMANESH R
    Covid-19 Infections in Vaccinated Health Care Workers.
    N Engl J Med. 2022;386.
    >> Share

  180. PAI M, Kasaeva T, Swaminathan S
    Covid-19's Devastating Effect on Tuberculosis Care - A Path to Recovery.
    N Engl J Med. 2022 Jan 5. doi: 10.1056/NEJMp2118145.
    >> Share

    December 2021
  181. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19 Vaccination and the Omicron Variant.
    N Engl J Med. 2021;385:e102.
    >> Share

  182. SCHMIDT F, Muecksch F, Weisblum Y, Da Silva J, et al
    Plasma Neutralization of the SARS-CoV-2 Omicron Variant.
    N Engl J Med. 2021 Dec 30. doi: 10.1056/NEJMc2119641.
    >> Share

  183. RITTENBERG E
    Trust, Faith, and Covid.
    N Engl J Med. 2021;385:2504-2505.
    >> Share

  184. NEMET I, Kliker L, Lustig Y, Zuckerman N, et al
    Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection.
    N Engl J Med. 2021 Dec 29. doi: 10.1056/NEJMc2119358.
    >> Share

  185. MCGREW S, Taylor HA
    Adolescents, Parents, and Covid-19 Vaccination - Who Should Decide?
    N Engl J Med. 2021 Dec 29. doi: 10.1056/NEJMp2116771.
    >> Share

  186. COLLIE S, Champion J, Moultrie H, Bekker LG, et al
    Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa.
    N Engl J Med. 2021 Dec 29. doi: 10.1056/NEJMc2119270.
    >> Share

  187. KISSLER SM, Fauver JR, Mack C, Tai CG, et al
    Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons.
    N Engl J Med. 2021;385:2489-2491.
    >> Share

  188. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A Potential New Agent to Treat Covid-19.
    N Engl J Med. 2021;385:e101.
    >> Share

  189. FOXWORTH R, Redvers N, Moreno MA, Lopez-Carmen VA, et al
    Covid-19 Vaccination in American Indians and Alaska Natives - Lessons from Effective Community Responses.
    N Engl J Med. 2021;385:2403-2406.
    >> Share

  190. GENG LN, Verghese A, Tilburt JC
    Consultative Medicine - An Emerging Specialty for Patients with Perplexing Conditions.
    N Engl J Med. 2021;385:2478-2484.
    >> Share

  191. GOTTLIEB RL, Vaca CE, Paredes R, Mera J, et al
    Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.
    N Engl J Med. 2021 Dec 22. doi: 10.1056/NEJMoa2116846.
    >> Share

  192. MUHSEN K, Maimon N, Mizrahi A, Varticovschi B, et al
    Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel.
    N Engl J Med. 2021 Dec 22. doi: 10.1056/NEJMc2117385.
    >> Share

  193. LACY J, Pavord S, Brown KE
    VITT and Second Doses of Covid-19 Vaccine.
    N Engl J Med. 2021 Dec 22. doi: 10.1056/NEJMc2118507.
    >> Share

  194. WHITLEY R
    Molnupiravir - A Step toward Orally Bioavailable Therapies for Covid-19.
    N Engl J Med. 2021 Dec 16. doi: 10.1056/NEJMe2117814.
    >> Share

  195. JAYK BERNAL A, Gomes da Silva MM, Musungaie DB, Kovalchuk E, et al
    Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.
    N Engl J Med. 2021 Dec 16. doi: 10.1056/NEJMoa2116044.
    >> Share

  196. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: How Much Protection Does Prior SARS-CoV-2 Infection Provide?
    N Engl J Med. 2021;385:e100.
    >> Share

  197. CHEMAITELLY H, Bertollini R, Abu-Raddad LJ
    Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant.
    N Engl J Med. 2021 Dec 15. doi: 10.1056/NEJMc2110300.
    >> Share

  198. MORENS DM, Taubenberger JK, Fauci AS
    Universal Coronavirus Vaccines - An Urgent Need.
    N Engl J Med. 2021 Dec 15. doi: 10.1056/NEJMp2118468.
    >> Share

  199. HORTON LE, Abeles SR, Torriani FJ
    SARS-CoV-2 Infection in Vaccinated Health Care Workers. Reply.
    N Engl J Med. 2021 Dec 15. pii: 10.1056/NEJMc2117119.
    >> Share

  200. LILLERI D, Marena C, Baldanti F
    SARS-CoV-2 Infection in Vaccinated Health Care Workers.
    N Engl J Med. 2021 Dec 15. pii: 10.1056/NEJMc2117119.
    >> Share

  201. DUNKLE LM, Kotloff KL, Gay CL, Anez G, et al
    Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
    N Engl J Med. 2021 Dec 15. doi: 10.1056/NEJMoa2116185.
    >> Share

  202. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Waning Immunity against SARS-CoV-2.
    N Engl J Med. 2021;385:e99.
    >> Share

  203. KNUDSEN J, Chokshi DA
    Covid-19 and the Safety Net - Moving from Straining to Sustaining.
    N Engl J Med. 2021;385:2209-2211.
    >> Share

  204. WALKER AS, Vihta KD, Gethings O, Pritchard E, et al
    Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom.
    N Engl J Med. 2021 Dec 8. doi: 10.1056/NEJMc2103227.
    >> Share

  205. PATEL MK
    Booster Doses and Prioritizing Lives Saved.
    N Engl J Med. 2021 Dec 8. doi: 10.1056/NEJMe2117592.
    >> Share

  206. ARBEL R, Hammerman A, Sergienko R, Friger M, et al
    BNT162b2 Vaccine Booster and Mortality Due to Covid-19.
    N Engl J Med. 2021 Dec 8. doi: 10.1056/NEJMoa2115624.
    >> Share

  207. MCGARRY BE, Barnett ML, Grabowski DC, Gandhi AD, et al
    Nursing Home Staff Vaccination and Covid-19 Outcomes.
    N Engl J Med. 2021 Dec 8. doi: 10.1056/NEJMc2115674.
    >> Share

  208. BAR-ON YM, Goldberg Y, Mandel M, Bodenheimer O, et al
    Protection against Covid-19 by BNT162b2 Booster across Age Groups.
    N Engl J Med. 2021 Dec 8. doi: 10.1056/NEJMoa2115926.
    >> Share

  209. RUBIN EJ, Baden LR, Abdool Karim SS, Morrissey S, et al
    Audio Interview: The Omicron Variant of SARS-CoV-2.
    N Engl J Med. 2021;385:e96.
    >> Share

  210. CAFORIO ALP
    Receipt of mRNA Vaccine against Covid-19 and Myocarditis.
    N Engl J Med. 2021;385:2189-2190.
    >> Share

  211. RUBIN EJ, Longo DL
    Covid-19 mRNA Vaccines - Six of One, Half a Dozen of the Other.
    N Engl J Med. 2021 Dec 1. doi: 10.1056/NEJMe2117446.
    >> Share

  212. ROSENBERG ES, Dorabawila V, Easton D, Bauer UE, et al
    Covid-19 Vaccine Effectiveness in New York State.
    N Engl J Med. 2021 Dec 1. doi: 10.1056/NEJMoa2116063.
    >> Share

  213. DICKERMAN BA, Gerlovin H, Madenci AL, Kurgansky KE, et al
    Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans.
    N Engl J Med. 2021 Dec 1. doi: 10.1056/NEJMoa2115463.
    >> Share

    November 2021
  214. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: What's Gone Right in Our Battle against Covid-19.
    N Engl J Med. 2021;385:e95.
    >> Share

  215. ABU-RADDAD LJ, Chemaitelly H, Bertollini R
    Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections.
    N Engl J Med. 2021 Nov 24. doi: 10.1056/NEJMc2108120.
    >> Share

  216. MURPHY WJ, Longo DL
    A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination.
    N Engl J Med. 2021 Nov 24. doi: 10.1056/NEJMcibr2113694.
    >> Share

  217. ZARYCHANSKI R, Lawler PR, Goligher E
    Therapeutic Anticoagulation with Heparin in Patients with Covid-19. Reply.
    N Engl J Med. 2021;385:2014.
    >> Share

  218. STERPETTI AV
    Therapeutic Anticoagulation with Heparin in Patients with Covid-19.
    N Engl J Med. 2021;385:2013-2014.
    >> Share

  219. FERNANDES TM, McGuire WC, Morris TA
    Therapeutic Anticoagulation with Heparin in Patients with Covid-19.
    N Engl J Med. 2021;385:2013.
    >> Share

  220. RUBIN EJ, Baden LR, Mello MM, Morrissey S, et al
    Audio Interview: The Legal Basis for Covid-19 Restrictions and Mandates.
    N Engl J Med. 2021;385:e88.
    >> Share

  221. RUBIN EJ, Baden LR, Grinsztejn B, Morrissey S, et al
    Audio Interview: Covid-19 in Brazil and New Evidence for Vaccinating Younger Children.
    N Engl J Med. 2021;385:e79.
    >> Share

  222. LOPEZ BERNAL J, Gower C, Andrews N
    Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. Reply.
    N Engl J Med. 2021 Nov 10. pii: 10.1056/NEJMc2113090.
    >> Share

  223. EMANI VR, Reddy R, Goswami S
    Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
    N Engl J Med. 2021 Nov 10. pii: 10.1056/NEJMc2113090.
    >> Share

  224. LINSENMEYER K, Gupta K, Charness ME
    Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
    N Engl J Med. 2021 Nov 10. pii: 10.1056/NEJMc2113090.
    >> Share

  225. TORGOVNICK J
    Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
    N Engl J Med. 2021 Nov 10. pii: 10.1056/NEJMc2113090.
    >> Share

  226. WALTER EB, Talaat KR, Sabharwal C, Gurtman A, et al
    Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
    N Engl J Med. 2021 Nov 9. doi: 10.1056/NEJMoa2116298.
    >> Share

  227. MONTO AS
    The Future of SARS-CoV-2 Vaccination - Lessons from Influenza.
    N Engl J Med. 2021 Nov 6. doi: 10.1056/NEJMp2113403.
    >> Share

  228. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Do We Have the Tools to End the Covid-19 Pandemic?
    N Engl J Med. 2021;385:e78.
    >> Share

  229. SCHONBORN L, Thiele T, Kaderali L, Greinacher A, et al
    Decline in Pathogenic Antibodies over Time in VITT.
    N Engl J Med. 2021;385:1815-1816.
    >> Share

  230. SCULLY M
    VITT after ChAdOx1 nCoV-19 Vaccination. Reply.
    N Engl J Med. 2021 Nov 3. pii: 10.1056/NEJMc2111026.
    >> Share

  231. GREINACHER A, Schonborn L, Thiele T
    VITT after ChAdOx1 nCoV-19 Vaccination. Reply.
    N Engl J Med. 2021 Nov 3. pii: 10.1056/NEJMc2111026.
    >> Share

  232. WEBER C, von Hundelshausen P, Siess W
    VITT after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021 Nov 3. pii: 10.1056/NEJMc2111026.
    >> Share

  233. SANTIN AD
    VITT after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021 Nov 3. pii: 10.1056/NEJMc2111026.
    >> Share

  234. URIU K, Kimura I, Shirakawa K, Takaori-Kondo A, et al
    Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum.
    N Engl J Med. 2021 Nov 3. doi: 10.1056/NEJMc2114706.
    >> Share

    October 2021
  235. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New Monoclonal Antibody for Covid-19 and Potential Vaccination for Children.
    N Engl J Med. 2021;385:e74.
    >> Share

  236. CHIN MH
    Uncomfortable Truths - What Covid-19 Has Revealed about Chronic-Disease Care in America.
    N Engl J Med. 2021;385:1633-1636.
    >> Share

  237. ASKENASE PW
    Rare Skin Reactions after mRNA Vaccination, Similar to Jones-Mote Basophil Responses.
    N Engl J Med. 2021;385:1720-1721.
    >> Share

  238. GUPTA A, Gonzalez-Rojas Y, Juarez E, Crespo Casal M, et al
    Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab.
    N Engl J Med. 2021 Oct 27. doi: 10.1056/NEJMoa2107934.
    >> Share

  239. GOLDBERG Y, Mandel M, Bar-On YM, Bodenheimer O, et al
    Waning Immunity after the BNT162b2 Vaccine in Israel.
    N Engl J Med. 2021 Oct 27. doi: 10.1056/NEJMoa2114228.
    >> Share

  240. DAGAN N, Barda N, Balicer RD
    Adverse Effects after BNT162b2 Vaccine and SARS-CoV-2 Infection, According to Age and Sex.
    N Engl J Med. 2021 Oct 27. doi: 10.1056/NEJMc2115045.
    >> Share

  241. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New Look at Covid-19 Vaccine Boosters.
    N Engl J Med. 2021;385:e72.
    >> Share

  242. MALLETT SD
    Peak Moments - When Kindergarten Is High Risk.
    N Engl J Med. 2021;385:1543-1545.
    >> Share

  243. MAGNUS MC, Gjessing HK, Eide HN, Wilcox AJ, et al
    Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage.
    N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114466.
    >> Share

  244. TEMPLE C, Hoang R, Hendrickson RG
    Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19.
    N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114907.
    >> Share

  245. CHIN ET, Leidner D, Zhang Y, Long E, et al
    Effectiveness of the mRNA-1273 Vaccine during a SARS-CoV-2 Delta Outbreak in a Prison.
    N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114089.
    >> Share

  246. SHEIKH A, Robertson C, Taylor B
    BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant.
    N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2113864.
    >> Share

  247. REIS BY, Barda N, Leshchinsky M, Kepten E, et al
    Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents.
    N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114290.
    >> Share

  248. COLLIER AY, Yu J, McMahan K, Liu J, et al
    Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines.
    N Engl J Med. 2021 Oct 15. doi: 10.1056/NEJMc2115596.
    >> Share

  249. RUBIN EJ, Baden LR, Wu KJ, Morrissey S, et al
    Audio Interview: Reporting on Covid-19.
    N Engl J Med. 2021;385:e66.
    >> Share

  250. HOCK H, Kelly HR, Meyerowitz EA, Frigault MJ, et al
    Case 31-2021: A 21-Year-Old Man with Sore Throat, Epistaxis, and Oropharyngeal Petechiae.
    N Engl J Med. 2021;385:1511-1520.
    >> Share

  251. BALSARI S, Kiang MV, Buckee CO
    Data in Crisis - Rethinking Disaster Preparedness in the United States.
    N Engl J Med. 2021;385:1526-1530.
    >> Share

  252. WHITE EM, Mor V
    SARS-CoV-2 Infection among Nursing Home Residents. Reply.
    N Engl J Med. 2021 Oct 13. pii: 10.1056/NEJMc2114113.
    >> Share

  253. CHANDRASEKAR B
    SARS-CoV-2 Infection among Nursing Home Residents.
    N Engl J Med. 2021 Oct 13. pii: 10.1056/NEJMc2114113.
    >> Share

  254. KORLEY FK, Durkalski-Mauldin V, Callaway CW
    Convalescent Plasma for Outpatients with Covid-19. Reply.
    N Engl J Med. 2021 Oct 13. pii: 10.1056/NEJMc2114591.
    >> Share

  255. SCHULZ E
    Convalescent Plasma for Outpatients with Covid-19.
    N Engl J Med. 2021 Oct 13. pii: 10.1056/NEJMc2114591.
    >> Share

  256. FISHER D, Malnick S
    Convalescent Plasma for Outpatients with Covid-19.
    N Engl J Med. 2021 Oct 13. pii: 10.1056/NEJMc2114591.
    >> Share

  257. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Are Covid-19 Vaccine Boosters Necessary?
    N Engl J Med. 2021;385:e63.
    >> Share

  258. WITBERG G, Barda N, Hoss S, Richter I, et al
    Myocarditis after Covid-19 Vaccination in a Large Health Care Organization.
    N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2110737.
    >> Share

  259. MEVORACH D, Anis E, Cedar N, Bromberg M, et al
    Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel.
    N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2109730.
    >> Share

  260. CHEMAITELLY H, Tang P, Hasan MR, AlMukdad S, et al
    Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.
    N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2114114.
    >> Share

  261. LEVIN EG, Lustig Y, Cohen C, Fluss R, et al
    Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.
    N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2114583.
    >> Share

  262. THOMPSON MG, Grant L, Meece J
    Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. Reply.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.
    >> Share

  263. ZHANG C, Yin G
    Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.
    >> Share

  264. SCHOOLEY RT
    Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.
    >> Share

  265. SANTACATTERINA M, Sanders JW, Weintraub WS
    Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.
    >> Share

  266. O'BRIEN MP, Hou P, Weinreich DM
    Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19. Reply.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113862.
    >> Share

  267. MERISON T, Goldman A, Bomze D
    Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113862.
    >> Share

    September 2021
  268. RUBIN EJ, Baden LR, Tofel R, Morrissey S, et al
    Audio Interview: Covid-19 and the Media.
    N Engl J Med. 2021;385:e59.
    >> Share

  269. WEINREICH DM, Sivapalasingam S, Norton T, Ali S, et al
    REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.
    N Engl J Med. 2021 Sep 29. doi: 10.1056/NEJMoa2108163.
    >> Share

  270. FALSEY AR, Sobieszczyk ME, Hirsch I, Sproule S, et al
    Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.
    N Engl J Med. 2021 Sep 29. doi: 10.1056/NEJMoa2105290.
    >> Share

  271. RAPEPORT G, Chiu C, McShane H
    SARS-CoV-2 Human Challenge Studies. Reply.
    N Engl J Med. 2021 Sep 29. pii: 10.1056/NEJMc2113574.
    >> Share

  272. STEUWER B, Eyal N
    SARS-CoV-2 Human Challenge Studies.
    N Engl J Med. 2021 Sep 29. pii: 10.1056/NEJMc2113574.
    >> Share

  273. AMIT S, Gonen T, Regev-Yochay G
    Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. Reply.
    N Engl J Med. 2021;385.
    >> Share

  274. JUNG J, Sung H, Kim SH
    Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
    N Engl J Med. 2021;385.
    >> Share

  275. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Vaccine Efficacy and Boosters in Covid-19.
    N Engl J Med. 2021;385:e54.
    >> Share

  276. ESSEX R, Weldon SM
    Health Care Worker Strikes and the Covid Pandemic. Reply.
    N Engl J Med. 2021;385:e43.
    >> Share

  277. CHAN SSC
    Health Care Worker Strikes and the Covid Pandemic.
    N Engl J Med. 2021;385:e43.
    >> Share

  278. SON MBF, Newburger JW, Randolph AG
    Therapy for Multisystem Inflammatory Syndrome in Children. Reply.
    N Engl J Med. 2021;385:e42.
    >> Share

  279. MCARDLE AJ, Cunnington AJ, Levin M
    Therapy for Multisystem Inflammatory Syndrome in Children. Reply.
    N Engl J Med. 2021;385:e42.
    >> Share

  280. OULDALI N, Belot A, Angoulvant F
    Therapy for Multisystem Inflammatory Syndrome in Children.
    N Engl J Med. 2021;385:e42.
    >> Share

  281. HARLEY JB
    Therapy for Multisystem Inflammatory Syndrome in Children.
    N Engl J Med. 2021;385:e42.
    >> Share

  282. EL SAHLY HM, Baden LR, Essink B, Doblecki-Lewis S, et al
    Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
    N Engl J Med. 2021 Sep 22. doi: 10.1056/NEJMoa2113017.
    >> Share

  283. PILISHVILI T, Gierke R, Fleming-Dutra KE, Farrar JL, et al
    Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel.
    N Engl J Med. 2021 Sep 22. doi: 10.1056/NEJMoa2106599.
    >> Share

  284. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: New Evidence on SARS-CoV-2 Vaccine Boosters.
    N Engl J Med. 2021;385:e48.
    >> Share

  285. NORTH CS, Sorg EM, Youn S, Chu JT, et al
    Case 28-2021: A 37-Year-Old Woman with Covid-19 and Suicidal Ideation.
    N Engl J Med. 2021;385:1125-1132.
    >> Share

  286. FRENCK RW JR, Dormitzer PR, Gurtman A
    BNT162b2 Covid-19 Vaccine in Adolescents. Reply.
    N Engl J Med. 2021;385.
    >> Share

  287. LIN CH
    BNT162b2 Covid-19 Vaccine in Adolescents.
    N Engl J Med. 2021;385.
    >> Share

  288. JARA A, Undurraga EA, Araos R
    Effectiveness of an Inactivated SARS-CoV-2 Vaccine. Reply.
    N Engl J Med. 2021;385.
    >> Share

  289. ONISHI FJ, Goto JM
    Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
    N Engl J Med. 2021;385.
    >> Share

  290. CHI H, Chiu NC, Lin CY
    Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
    N Engl J Med. 2021;385.
    >> Share

  291. OKHOTIN A
    Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
    N Engl J Med. 2021;385.
    >> Share

  292. THOMAS SJ, Moreira ED Jr, Kitchin N, Absalon J, et al
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.
    N Engl J Med. 2021 Sep 15. doi: 10.1056/NEJMoa2110345.
    >> Share

  293. FALSEY AR, Frenck RW Jr, Walsh EE, Kitchin N, et al
    SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.
    N Engl J Med. 2021 Sep 15. doi: 10.1056/NEJMc2113468.
    >> Share

  294. BAR-ON YM, Goldberg Y, Mandel M, Bodenheimer O, et al
    Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel.
    N Engl J Med. 2021 Sep 15. doi: 10.1056/NEJMoa2114255.
    >> Share

  295. SALIH F, Schonborn L, Kohler S, Franke C, et al
    Vaccine-Induced Thrombocytopenia with Severe Headache.
    N Engl J Med. 2021 Sep 15. doi: 10.1056/NEJMc2112974.
    >> Share


  296. Surviving Covid-19 with Heparin?
    N Engl J Med. 2021;385:1056.
    >> Share

  297. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Protecting against Severe Disease and Transmission.
    N Engl J Med. 2021;385:e44.
    >> Share

  298. SHAH ASV, Gribben C, Bishop J, Hanlon P, et al
    Effect of Vaccination on Transmission of SARS-CoV-2.
    N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMc2106757.
    >> Share

  299. MEANEY-DELMAN DM, Ellington SR, Shimabukuro TT
    On Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. Reply.
    N Engl J Med. 2021 Sep 8. pii: 10.1056/NEJMc2113516.
    >> Share

  300. SUN H
    On Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons.
    N Engl J Med. 2021 Sep 8. pii: 10.1056/NEJMc2113516.
    >> Share

  301. ZAUCHE LH, Wallace B, Smoots AN, Olson CK, et al
    Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion.
    N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMc2113891.
    >> Share

  302. DEAN NE, Hogan JW, Schnitzer ME
    Covid-19 Vaccine Effectiveness and the Test-Negative Design.
    N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMe2113151.
    >> Share

  303. THOMPSON MG, Stenehjem E, Grannis S, Ball SW, et al
    Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings.
    N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMoa2110362.
    >> Share


  304. mRNA Covid-19 Vaccines in Pregnant Women.
    N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMx210017.
    >> Share


  305. Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons.
    N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMx210016.
    >> Share

  306. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New Round of Rising Covid-19 Numbers.
    N Engl J Med. 2021;385:e41.
    >> Share

  307. WILDER-SMITH A, Mulholland K
    Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
    N Engl J Med. 2021;385:946-948.
    >> Share

  308. WERNER RM, Glied SA
    Covid-Induced Changes in Health Care Delivery - Can They Last?
    N Engl J Med. 2021;385:868-870.
    >> Share

  309. KEEHNER J, Horton LE, Binkin NJ, Laurent LC, et al
    Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce.
    N Engl J Med. 2021 Sep 1. doi: 10.1056/NEJMc2112981.
    >> Share

  310. MELLO MM, Parmet WE
    Public Health Law after Covid-19.
    N Engl J Med. 2021 Sep 1. doi: 10.1056/NEJMp2112193.
    >> Share

    August 2021
  311. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Assessing Vaccine Safety.
    N Engl J Med. 2021;385:e37.
    >> Share

  312. LEVY JH, Connors JM
    Heparin Resistance - Clinical Perspectives and Management Strategies.
    N Engl J Med. 2021;385:826-832.
    >> Share

  313. PAPINENI P
    A Pink Salwar.
    N Engl J Med. 2021;385:774-775.
    >> Share

  314. UZUN G, Althaus K, Bakchoul T
    No Correlation between Anti-PF4 and Anti-SARS-CoV-2 Antibodies after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMc2111305.
    >> Share

  315. BARDA N, Dagan N, Ben-Shlomo Y, Kepten E, et al
    Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.
    N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMoa2110475.
    >> Share

  316. LEE GM
    The Importance of Context in Covid-19 Vaccine Safety.
    N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMe2112543.
    >> Share

  317. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Aspects of Covid-19 Immunity.
    N Engl J Med. 2021;385:e31.
    >> Share

  318. TAN CW, Chia WN, Young BE, Zhu F, et al
    Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors.
    N Engl J Med. 2021 Aug 18. doi: 10.1056/NEJMoa2108453.
    >> Share

  319. VERMA AK, Lavine KJ, Lin CY
    Myocarditis after Covid-19 mRNA Vaccination.
    N Engl J Med. 2021 Aug 18. doi: 10.1056/NEJMc2109975.
    >> Share

  320. KORLEY FK, Durkalski-Mauldin V, Yeatts SD, Schulman K, et al
    Early Convalescent Plasma for High-Risk Outpatients with Covid-19.
    N Engl J Med. 2021 Aug 18. doi: 10.1056/NEJMoa2103784.
    >> Share

  321. ROSAS IO, Raby B, Tsai L
    Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. Reply.
    N Engl J Med. 2021 Aug 18. pii: 10.1056/NEJMc2108482.
    >> Share

  322. GORDON AC, Angus DC, Derde LPG
    Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. Reply.
    N Engl J Med. 2021 Aug 18. pii: 10.1056/NEJMc2108482.
    >> Share

  323. BROWN MJ, Alazawi W, Kanoni S
    Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
    N Engl J Med. 2021 Aug 18. pii: 10.1056/NEJMc2108482.
    >> Share

  324. LANGE B, Gerigk M, Tenenbaum T
    Breakthrough Infections in BNT162b2-Vaccinated Health Care Workers.
    N Engl J Med. 2021 Aug 18. doi: 10.1056/NEJMc2108076.
    >> Share

  325. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Monoclonal Antibodies and Booster Shots.
    N Engl J Med. 2021;385:e29.
    >> Share

  326. BARAS SHREIBATI J
    When Low Tech Wins.
    N Engl J Med. 2021;385:581-583.
    >> Share

  327. PHILLIPS S, Williams MA
    Confronting Our Next National Health Disaster - Long-Haul Covid.
    N Engl J Med. 2021;385:577-579.
    >> Share

  328. ALI K, Berman G, Zhou H, Deng W, et al
    Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents.
    N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMoa2109522.
    >> Share

  329. PAVORD S, Scully M, Hunt BJ, Lester W, et al
    Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
    N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMoa2109908.
    >> Share

  330. WILLIAMS WW, Ingelfinger JR
    Third Time's a Charm - Covid-19 Vaccine Hope for Solid-Organ Transplant Recipients.
    N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMe2112866.
    >> Share

  331. HALL VG, Ferreira VH, Ku T, Ierullo M, et al
    Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.
    N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMc2111462.
    >> Share

  332. COREY L, Beyrer C, Cohen MS, Michael NL, et al
    SARS-CoV-2 Variants in Patients with Immunosuppression.
    N Engl J Med. 2021;385:562-566.
    >> Share

  333. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Looking Back and Looking Forward - Part 2.
    N Engl J Med. 2021;385:e25.
    >> Share

  334. GOLIGHER EC, Bradbury CA, McVerry BJ, Lawler PR, et al
    Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
    N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMoa2103417.
    >> Share

  335. LAWLER PR, Goligher EC, Berger JS, Neal MD, et al
    Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
    N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMoa2105911.
    >> Share

  336. O'BRIEN MP, Forleo-Neto E, Musser BJ, Isa F, et al
    Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
    N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMoa2109682.
    >> Share

  337. TEN CATE H
    Surviving Covid-19 with Heparin?
    N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMe2111151.
    >> Share

    July 2021
  338. GUIMARAES PO, Quirk D, Furtado RH, Maia LN, et al
    Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia.
    N Engl J Med. 2021;385:406-415.
    >> Share

  339. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Looking Back and Looking Forward - Part 1.
    N Engl J Med. 2021;385:e24.
    >> Share

  340. BERGWERK M, Gonen T, Lustig Y, Amit S, et al
    Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
    N Engl J Med. 2021 Jul 28. doi: 10.1056/NEJMoa2109072.
    >> Share

  341. RUBIN EJ, Baden LR, Armstrong KA, Morrissey S, et al
    Audio Interview: The Impact of Covid-19 on Trainees and Junior Faculty.
    N Engl J Med. 2021;385:e21.
    >> Share

  342. LOPEZ BERNAL J, Andrews N, Gower C, Gallagher E, et al
    Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
    N Engl J Med. 2021 Jul 21. doi: 10.1056/NEJMoa2108891.
    >> Share

  343. RAPEPORT G, Smith E, Gilbert A, Catchpole A, et al
    SARS-CoV-2 Human Challenge Studies - Establishing the Model during an Evolving Pandemic.
    N Engl J Med. 2021 Jul 21. doi: 10.1056/NEJMp2106970.
    >> Share

  344. CHU VT, Yousaf AR, Chang K, Schwartz NG, et al
    Household Transmission of SARS-CoV-2 from Children and Adolescents.
    N Engl J Med. 2021 Jul 21. doi: 10.1056/NEJMc2031915.
    >> Share

  345. MADHI SA, Izu A, Pollard AJ
    ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant. Reply.
    N Engl J Med. 2021;385.
    >> Share

  346. STRUYF F, Sadoff J, Douoguih M
    ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant.
    N Engl J Med. 2021;385.
    >> Share

  347. EICHINGER S, Warkentin TE, Greinacher A
    Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. Reply.
    N Engl J Med. 2021;385:e11.
    >> Share

  348. CHOI PY
    Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021;385:e11.
    >> Share

  349. LAI KY, Au SY, Fong KM
    Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021;385:e11.
    >> Share

  350. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Monoclonal Antibodies and Vaccine Boosts.
    N Engl J Med. 2021;385:e18.
    >> Share

  351. MOON S, Alonso Ruiz A, Vieira M
    Averting Future Vaccine Injustice.
    N Engl J Med. 2021;385:193-196.
    >> Share

  352. NORMARK J, Vikstrom L, Gwon YD, Persson IL, et al
    Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
    N Engl J Med. 2021 Jul 14. doi: 10.1056/NEJMc2110716.
    >> Share

  353. DOUGAN M, Nirula A, Azizad M, Mocherla B, et al
    Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
    N Engl J Med. 2021 Jul 14. doi: 10.1056/NEJMoa2102685.
    >> Share

  354. BAROUCH DH, Stephenson KE, Sadoff J, Yu J, et al
    Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination.
    N Engl J Med. 2021 Jul 14. doi: 10.1056/NEJMc2108829.
    >> Share

  355. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: How Well Are Covid-19 Vaccines Working?
    N Engl J Med. 2021;385:e15.
    >> Share

  356. BRINKLEY-RUBINSTEIN L, Peterson M, Martin R, Chan P, et al
    Breakthrough SARS-CoV-2 Infections in Prison after Vaccination.
    N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2108479.
    >> Share

  357. JARA A, Undurraga EA, Gonzalez C, Paredes F, et al
    Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.
    N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMoa2107715.
    >> Share

  358. EDARA VV, Pinsky BA, Suthar MS, Lai L, et al
    Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.
    N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2107799.
    >> Share

  359. PATRIQUIN CJ, Laroche V, Selby R, Pendergrast J, et al
    Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2109465.
    >> Share

  360. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Another New Covid-19 Vaccine.
    N Engl J Med. 2021;385:e13.
    >> Share

  361. SON MBF, Murray N, Friedman K, Young CC, et al
    Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.
    N Engl J Med. 2021;385:23-34.
    >> Share

  362. MCARDLE AJ, Vito O, Patel H, Seaby EG, et al
    Treatment of Multisystem Inflammatory Syndrome in Children.
    N Engl J Med. 2021;385:11-22.
    >> Share

  363. ROPPER AH, Klein JP
    Cerebral Venous Thrombosis.
    N Engl J Med. 2021;385:59-64.
    >> Share

    June 2021
  364. THOMPSON MG, Burgess JL, Naleway AL, Tyner H, et al
    Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
    N Engl J Med. 2021 Jun 30. doi: 10.1056/NEJMoa2107058.
    >> Share

  365. HEATH PT, Galiza EP, Baxter DN, Boffito M, et al
    Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.
    N Engl J Med. 2021 Jun 30. doi: 10.1056/NEJMoa2107659.
    >> Share

  366. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New mRNA Vaccine.
    N Engl J Med. 2021;384:e109.
    >> Share

  367. HARRIS RJ, Hall JA, Zaidi A, Andrews NJ, et al
    Effect of Vaccination on Household Transmission of SARS-CoV-2 in England.
    N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMc2107717.
    >> Share

  368. KAMAR N, Abravanel F, Marion O, Couat C, et al
    Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.
    N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMc2108861.
    >> Share

  369. KRAUSE PR, Fleming TR, Longini IM, Peto R, et al
    SARS-CoV-2 Variants and Vaccines.
    N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMsr2105280.
    >> Share

  370. RUBIN EJ, Baden LR, Ingelfinger JR, Morrissey S, et al
    Audio Interview: Covid-19 in Children.
    N Engl J Med. 2021;384:e108.
    >> Share

  371. KOENIG PA, Schmidt FI
    Spike D614G - A Candidate Vaccine Antigen Against Covid-19.
    N Engl J Med. 2021;384:2349-2351.
    >> Share

  372. RILEY LE
    mRNA Covid-19 Vaccines in Pregnant Women.
    N Engl J Med. 2021;384:2342-2343.
    >> Share

  373. JAGSI R, Fuentes-Afflick E, Higginbotham E
    Promoting Equity for Women in Medicine - Seizing a Disruptive Opportunity.
    N Engl J Med. 2021;384:2265-2267.
    >> Share

  374. HIBBERT KA, Goiffon RJ, Fogerty AE
    Case 18-2021: An 81-Year-Old Man with Cough, Fever, and Shortness of Breath.
    N Engl J Med. 2021;384:2332-2340.
    >> Share

  375. ESSEX R, Weldon SM
    Health Care Worker Strikes and the Covid Pandemic.
    N Engl J Med. 2021;384:e93.
    >> Share


  376. SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    N Engl J Med. 2021;384:e92.
    >> Share

  377. RUBIN EJ, Baden LR, Longo DL, Morrissey S, et al
    Audio Interview: Treating Complications of Covid Vaccination.
    N Engl J Med. 2021;384:e107.
    >> Share

  378. BECKER SJ, Taylor J, Sharfstein JM
    Identifying and Tracking SARS-CoV-2 Variants - A Challenge and an Opportunity.
    N Engl J Med. 2021 Jun 9. doi: 10.1056/NEJMp2103859.
    >> Share

  379. BOURGUIGNON A, Arnold DM, Warkentin TE, Smith JW, et al
    Adjunct Immune Globulin for Vaccine-Induced Thrombotic Thrombocytopenia.
    N Engl J Med. 2021 Jun 9. doi: 10.1056/NEJMoa2107051.
    >> Share

  380. VANDEBOSCH A, Sadoff J, Douoguih M
    Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. Reply.
    N Engl J Med. 2021 Jun 9. pii: 10.1056/NEJMc2107809.
    >> Share

  381. HEININGER U
    Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
    N Engl J Med. 2021 Jun 9. pii: 10.1056/NEJMc2107809.
    >> Share

  382. SAMARAKOON U, Alvarez-Arango S, Blumenthal KG
    Delayed Large Local Reactions to mRNA Covid-19 Vaccines in Blacks, Indigenous Persons, and People of Color.
    N Engl J Med. 2021 Jun 9. doi: 10.1056/NEJMc2108620.
    >> Share

  383. NEWMAN AM
    Institutional Problems, Individual Solutions - The Burden on Black Physicians.
    N Engl J Med. 2021;384:2076-2078.
    >> Share

  384. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Vaccinating Children.
    N Engl J Med. 2021;384:e103.
    >> Share

  385. BLACHERE NE, Hacisuleyman E, Darnell RB
    Vaccine Breakthrough Infections with SARS-CoV-2 Variants. Reply.
    N Engl J Med. 2021 Jun 2. pii: 10.1056/NEJMc2107808.
    >> Share

  386. RANA K, Mohindra R, Pinnaka L
    Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
    N Engl J Med. 2021 Jun 2. pii: 10.1056/NEJMc2107808.
    >> Share

  387. NIXON DF, Ndhlovu LC
    Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
    N Engl J Med. 2021 Jun 2. pii: 10.1056/NEJMc2107808.
    >> Share

  388. TAKUVA S, Takalani A, Garrett N, Goga A, et al
    Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study.
    N Engl J Med. 2021 Jun 2. doi: 10.1056/NEJMc2107920.
    >> Share

    May 2021
  389. FRENCK RW JR, Klein NP, Kitchin N, Gurtman A, et al
    Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.
    N Engl J Med. 2021 May 27. doi: 10.1056/NEJMoa2107456.
    >> Share

  390. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Protecting the Immunosuppressed against Covid-19.
    N Engl J Med. 2021;384:e88.
    >> Share

  391. BURRIS S, Anderson ED, Wagenaar AC
    The "Legal Epidemiology" of Pandemic Control.
    N Engl J Med. 2021;384:1973-1975.
    >> Share

  392. VOLPP KG, Cannuscio CC
    Incentives for Immunity - Strategies for Increasing Covid-19 Vaccine Uptake.
    N Engl J Med. 2021 May 26. doi: 10.1056/NEJMp2107719.
    >> Share

  393. SPARROW AK, Brosseau LM, Harrison RJ, Osterholm MT, et al
    Protecting Olympic Participants from Covid-19 - The Urgent Need for a Risk-Management Approach.
    N Engl J Med. 2021 May 25. doi: 10.1056/NEJMp2108567.
    >> Share

  394. RUBIN EJ, Baden LR, Drazen JM, Taichman DB, et al
    Audio Interview: Vaccination in Nursing Homes and New Pulmonary/Critical Care Research.
    N Engl J Med. 2021;384:e89.
    >> Share

  395. O'CONNELL J, O'Keeffe DT
    Contact Tracing for Covid-19 - A Digital Inoculation against Future Pandemics.
    N Engl J Med. 2021 May 19. doi: 10.1056/NEJMp2102256.
    >> Share

  396. WHITE EM, Yang X, Blackman C, Feifer RA, et al
    Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents.
    N Engl J Med. 2021 May 19. doi: 10.1056/NEJMc2104849.
    >> Share

  397. RUBIN EJ, Baden LR, Gray GE, Morrissey S, et al
    Audio Interview: Vaccination and Variants in the U.S. and South Africa.
    N Engl J Med. 2021;384:e85.
    >> Share

  398. RODRIGUEZ-HERNANDEZ M, Pilato TC, Yerdon KA, Kysel IM, et al
    Detained.
    N Engl J Med. 2021;384:1785-1787.
    >> Share

  399. WAPPNER D, Bergel E, Polack FP
    Plasma Therapy to Prevent Severe Covid-19 in Older Adults. Reply.
    N Engl J Med. 2021 May 12. pii: 10.1056/NEJMc2104747.
    >> Share

  400. RAGUSA M, Tortosa F, Izcovich A
    Plasma Therapy to Prevent Severe Covid-19 in Older Adults.
    N Engl J Med. 2021 May 12. pii: 10.1056/NEJMc2104747.
    >> Share

  401. KLAMT F, Parsons RB, Jones MH
    Plasma Therapy to Prevent Severe Covid-19 in Older Adults.
    N Engl J Med. 2021 May 12. pii: 10.1056/NEJMc2104747.
    >> Share

  402. KEEHNER J, Abeles SR, Torriani FJ
    More on SARS-CoV-2 Infection after Vaccination in Health Care Workers. Reply.
    N Engl J Med. 2021 May 12. pii: 10.1056/NEJMc2106004.
    >> Share

  403. TOSONI A, Mirijello A, Addolorato G
    More on SARS-CoV-2 Infection after Vaccination in Health Care Workers.
    N Engl J Med. 2021 May 12. pii: 10.1056/NEJMc2106004.
    >> Share

  404. SCALES D, Gorman J, Jamieson KH
    The Covid-19 Infodemic - Applying the Epidemiologic Model to Counter Misinformation.
    N Engl J Med. 2021 May 12. doi: 10.1056/NEJMp2103798.
    >> Share

  405. CHIN ET, Leidner D, Ryckman T, Liu YE, et al
    Covid-19 Vaccine Acceptance in California State Prisons.
    N Engl J Med. 2021 May 12. doi: 10.1056/NEJMc2105282.
    >> Share

  406. LIU Y, Liu J, Xia H, Zhang X, et al
    BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants.
    N Engl J Med. 2021 May 12. doi: 10.1056/NEJMc2106083.
    >> Share

  407. RUBIN EJ, Baden LR, Udwadia ZF, Morrissey S, et al
    Audio Interview: India's Covid-19 Crisis.
    N Engl J Med. 2021;384:e84.
    >> Share

  408. SALWA J, Robertson C
    Designing an Independent Public Health Agency.
    N Engl J Med. 2021;384:1684-1687.
    >> Share

  409. RATZAN S, Schneider EC, Hatch H, Cacchione J, et al
    Missing the Point - How Primary Care Can Overcome Covid-19 Vaccine "Hesitancy".
    N Engl J Med. 2021 May 5. doi: 10.1056/NEJMp2106137.
    >> Share

  410. SHINDE V, Bhikha S, Hoosain Z, Archary M, et al
    Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.
    N Engl J Med. 2021 May 5. doi: 10.1056/NEJMoa2103055.
    >> Share

  411. NEUZIL KM
    Interplay between Emerging SARS-CoV-2 Variants and Pandemic Control.
    N Engl J Med. 2021 May 5. doi: 10.1056/NEJMe2103931.
    >> Share

  412. ABU-RADDAD LJ, Chemaitelly H, Butt AA
    Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants.
    N Engl J Med. 2021 May 5. doi: 10.1056/NEJMc2104974.
    >> Share

    April 2021
  413. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Advice for Clinicians on Covid-19 Vaccines and Social Restrictions.
    N Engl J Med. 2021;384:e77.
    >> Share

  414. KADAKIA KT, Beckman AL, Ross JS, Krumholz HM, et al
    Leveraging Open Science to Accelerate Research.
    N Engl J Med. 2021;384:e61.
    >> Share

  415. GOLDFARB JL, Kreps S, Brownstein JS, Kriner DL, et al
    Beyond the First Dose - Covid-19 Vaccine Follow-through and Continued Protective Measures.
    N Engl J Med. 2021 Apr 28. doi: 10.1056/NEJMp2104527.
    >> Share

  416. FAJGENBAUM DC, June CH
    Cytokine Storm. Reply.
    N Engl J Med. 2021;384:e59.
    >> Share

  417. MUDD PA, Crawford JC, Thomas PG
    Cytokine Storm.
    N Engl J Med. 2021;384:e59.
    >> Share

  418. SUPADY A, Bode C, Duerschmied D
    Cytokine Storm.
    N Engl J Med. 2021;384:e59.
    >> Share

  419. GAESTEL M, Nebreda AR, Yaffe MB
    Cytokine Storm.
    N Engl J Med. 2021;384:e59.
    >> Share

  420. RUBIN EJ, Baden LR, Walensky RP, Morrissey S, et al
    Audio Interview: Covid-19 Vaccines and Pregnancy - A Conversation with CDC Director Rochelle Walensky.
    N Engl J Med. 2021;384:e73.
    >> Share

  421. DODD LE, Freidlin B, Korn EL
    Platform Trials - Beware the Noncomparable Control Group.
    N Engl J Med. 2021;384:1572-1573.
    >> Share

  422. BARDA N, Dagan N, Balicer RD
    BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. Reply.
    N Engl J Med. 2021;384.
    >> Share

  423. ROEST S, Hoek RAS, Manintveld OC
    BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.
    N Engl J Med. 2021;384.
    >> Share

  424. SADOFF J, Gray G, Vandebosch A, Cardenas V, et al
    Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
    N Engl J Med. 2021 Apr 21. doi: 10.1056/NEJMoa2101544.
    >> Share

  425. CANELLI R, Shrestha GS, Ortega R
    Emergency Intubation in Covid-19. Reply.
    N Engl J Med. 2021;384.
    >> Share

  426. PATEL J, Janapala RN, Pourmand A
    Emergency Intubation in Covid-19.
    N Engl J Med. 2021;384.
    >> Share

  427. SELLERS WFS
    Emergency Intubation in Covid-19.
    N Engl J Med. 2021;384.
    >> Share

  428. HERZOG N, Giacardi C, Danguy des Deserts M
    Emergency Intubation in Covid-19.
    N Engl J Med. 2021;384.
    >> Share

  429. HACISULEYMAN E, Hale C, Saito Y, Blachere NE, et al
    Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
    N Engl J Med. 2021 Apr 21. doi: 10.1056/NEJMoa2105000.
    >> Share

  430. SHIMABUKURO TT, Kim SY, Myers TR, Moro PL, et al
    Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons.
    N Engl J Med. 2021 Apr 21. doi: 10.1056/NEJMoa2104983.
    >> Share

  431. BAECK M, Marot L, Belkhir L
    Delayed Large Local Reactions to mRNA Vaccines.
    N Engl J Med. 2021 Apr 21. pii: 10.1056/NEJMc2104751.
    >> Share

  432. SCULLY M, Singh D, Lown R, Poles A, et al
    Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021 Apr 16. doi: 10.1056/NEJMoa2105385.
    >> Share

  433. CINES DB, Bussel JB
    SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    N Engl J Med. 2021 Apr 16. doi: 10.1056/NEJMe2106315.
    >> Share

  434. MECKLAI K, Smith N, Stern AD, Kramer DB, et al
    Remote Patient Monitoring - Overdue or Overused?
    N Engl J Med. 2021;384:1384-1386.
    >> Share

  435. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Vaccine Successes and Vaccine Adverse Events.
    N Engl J Med. 2021;384:e70.
    >> Share

  436. ROSENBAUM L
    No Cure without Care - Soothing Science Skepticism.
    N Engl J Med. 2021;384:1462-1465.
    >> Share

  437. LIU Y, Liu J, Xia H, Zhang X, et al
    Neutralizing Activity of BNT162b2-Elicited Serum.
    N Engl J Med. 2021;384:1466-1468.
    >> Share

  438. ANICHINI G, Terrosi C, Gandolfo C, Gori Savellini G, et al
    SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.
    N Engl J Med. 2021 Apr 14. doi: 10.1056/NEJMc2103825.
    >> Share

  439. MUIR KL, Kallam A, Koepsell SA, Gundabolu K, et al
    Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination.
    N Engl J Med. 2021 Apr 14. doi: 10.1056/NEJMc2105869.
    >> Share

  440. GREINACHER A, Thiele T, Warkentin TE, Weisser K, et al
    Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
    N Engl J Med. 2021 Apr 9. doi: 10.1056/NEJMoa2104840.
    >> Share

  441. SCHULTZ NH, Sorvoll IH, Michelsen AE, Munthe LA, et al
    Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021 Apr 9. doi: 10.1056/NEJMoa2104882.
    >> Share

  442. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Antibody Responses to Natural Infection and Vaccination.
    N Engl J Med. 2021;384:e65.
    >> Share

  443. KATZ IT, Weintraub R, Bekker LG, Brandt AM, et al
    From Vaccine Nationalism to Vaccine Equity - Finding a Path Forward.
    N Engl J Med. 2021;384:1281-1283.
    >> Share

  444. SHEN X, Tang H, Pajon R, Smith G, et al
    Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351.
    N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMc2103740.
    >> Share

  445. SASISEKHARAN R
    Preparing for the Future - Nanobodies for Covid-19?
    N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMcibr2101205.
    >> Share

  446. MOYO-GWETE T, Madzivhandila M, Makhado Z, Ayres F, et al
    Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351).
    N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMc2104192.
    >> Share

  447. LUSTIG Y, Nemet I, Kliker L, Zuckerman N, et al
    Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2.
    N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMc2104036.
    >> Share

  448. DORIA-ROSE N, Suthar MS, Makowski M, O'Connell S, et al
    Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.
    N Engl J Med. 2021 Apr 6. doi: 10.1056/NEJMc2103916.
    >> Share

  449. KIM MC, Park MS, Chung JW
    Viable SARS-CoV-2 Shedding. Reply.
    N Engl J Med. 2021;384.
    >> Share

  450. ROMANO CM, Felix AC, Pannuti CS
    Viable SARS-CoV-2 Shedding.
    N Engl J Med. 2021;384.
    >> Share

  451. WANG GL, Wang ZY, Duan LJ, Meng QC, et al
    Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization.
    N Engl J Med. 2021 Apr 6. doi: 10.1056/NEJMc2103022.
    >> Share

  452. RUBIN EJ, Baden LR, Del Rio C, Akusobi C, et al
    Audio Interview: Delivering Covid-19 Vaccines to Minority Communities.
    N Engl J Med. 2021;384:e60.
    >> Share

  453. ELIAS C, Nkengasong JN, Qadri F
    Emerging Infectious Diseases - Learning from the Past and Looking to the Future.
    N Engl J Med. 2021;384:1181-1184.
    >> Share

    March 2021
  454. NACHEGA JB, Sam-Agudu NA, Mellors JW, Zumla A, et al
    Scaling Up Covid-19 Vaccination in Africa - Lessons from the HIV Pandemic.
    N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2103313.
    >> Share

  455. QUINN SC, Andrasik MP
    Addressing Vaccine Hesitancy in BIPOC Communities - Toward Trustworthiness, Partnership, and Reciprocity.
    N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2103104.
    >> Share

  456. HALL MA, Studdert DM
    "Vaccine Passport" Certification - Policy and Ethical Considerations.
    N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2104289.
    >> Share

  457. RUBIN EJ, Baden LR, Brandt AM, Morrissey S, et al
    Audio Interview: What Earlier Epidemics Teach Us about Covid-19.
    N Engl J Med. 2021;384:e55.
    >> Share

  458. DESMOND A, Offit PA
    On the Shoulders of Giants - From Jenner's Cowpox to mRNA Covid Vaccines.
    N Engl J Med. 2021;384:1081-1083.
    >> Share

  459. KADIRE SR, Fabre V, Wenzel RP
    Doctor, How Long Should I Isolate?
    N Engl J Med. 2021;384:e47.
    >> Share

  460. ONI-ORISAN A, Mavura Y, Banda Y, Thornton TA, et al
    Embracing Genetic Diversity to Improve Black Health.
    N Engl J Med. 2021;384:1163-1167.
    >> Share

  461. ARMSTRONG K
    Covid-19 and the Investigator Pipeline.
    N Engl J Med. 2021 Mar 24. doi: 10.1056/NEJMp2100086.
    >> Share

  462. ABDOOL KARIM SS, de Oliveira T
    New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications.
    N Engl J Med. 2021 Mar 24. doi: 10.1056/NEJMc2100362.
    >> Share

  463. KEEHNER J, Horton LE, Pfeffer MA, Longhurst CA, et al
    SARS-CoV-2 Infection after Vaccination in Health Care Workers in California.
    N Engl J Med. 2021 Mar 23. doi: 10.1056/NEJMc2101927.
    >> Share

  464. BRADLEY T, Grundberg E, Selvarangan R, LeMaster C, et al
    Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine.
    N Engl J Med. 2021 Mar 23. doi: 10.1056/NEJMc2102051.
    >> Share

  465. DANIEL W, Nivet M, Warner J, Podolsky DK, et al
    Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center.
    N Engl J Med. 2021 Mar 23. doi: 10.1056/NEJMc2102153.
    >> Share

  466. BENENSON S, Oster Y, Cohen MJ, Nir-Paz R, et al
    BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers.
    N Engl J Med. 2021 Mar 23. doi: 10.1056/NEJMc2101951.
    >> Share

  467. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Efficacy of Current Covid-19 Vaccines against Variant Viruses.
    N Engl J Med. 2021;384:e53.
    >> Share

  468. WU K, Werner AP, Koch M, Choi A, et al
    Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine.
    N Engl J Med. 2021 Mar 17. doi: 10.1056/NEJMc2102179.
    >> Share

  469. MADHI SA, Baillie V, Cutland CL, Voysey M, et al
    Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.
    N Engl J Med. 2021 Mar 16. doi: 10.1056/NEJMoa2102214.
    >> Share

  470. KRUTIKOV M, Hayward A, Shallcross L
    Spread of a Variant SARS-CoV-2 in Long-Term Care Facilities in England.
    N Engl J Med. 2021 Mar 16. doi: 10.1056/NEJMc2035906.
    >> Share

  471. RUBIN EJ, Baden LR, Abraham J, Morrissey S, et al
    Audio Interview: The Implications of Changes in the Structural Biology of SARS-CoV-2.
    N Engl J Med. 2021;384:e48.
    >> Share

  472. CARTER S
    Breathless.
    N Engl J Med. 2021;384:891-893.
    >> Share

  473. POOLE MK, Fleischhacker SE, Bleich SN
    Addressing Child Hunger When School Is Closed - Considerations during the Pandemic and Beyond.
    N Engl J Med. 2021;384:e35.
    >> Share

  474. KRAMMER F, Srivastava K, Alshammary H, Amoako AA, et al
    Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.
    N Engl J Med. 2021 Mar 10. doi: 10.1056/NEJMc2101667.
    >> Share

  475. GORALNICK E, Kaufmann C, Gawande AA
    Mass-Vaccination Sites - An Essential Innovation to Curb the Covid-19 Pandemic.
    N Engl J Med. 2021 Mar 10. doi: 10.1056/NEJMp2102535.
    >> Share

  476. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New SARS-CoV-2 Vaccine and a New Look at Treatment.
    N Engl J Med. 2021;384:e46.
    >> Share

  477. GOLETTI D, Cantini F
    Baricitinib Therapy in Covid-19 Pneumonia - An Unmet Need Fulfilled.
    N Engl J Med. 2021;384:867-869.
    >> Share

  478. BLUMENTHAL KG, Freeman EE, Saff RR, Robinson LB, et al
    Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2.
    N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMc2102131.
    >> Share

  479. STEELFISHER GK, Blendon RJ, Caporello H
    An Uncertain Public - Encouraging Acceptance of Covid-19 Vaccines.
    N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMp2100351.
    >> Share

  480. BARSKY BA, Reinhart E, Farmer P, Keshavjee S, et al
    Vaccination plus Decarceration - Stopping Covid-19 in Jails and Prisons.
    N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMp2100609.
    >> Share

  481. KRAMER DB, Opel DJ, Parasidis E, Mello MM, et al
    Choices in a Crisis - Individual Preferences among SARS-CoV-2 Vaccines.
    N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMp2102146.
    >> Share

  482. STONE JH
    Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. Reply.
    N Engl J Med. 2021 Mar 3. pii: 10.1056/NEJMc2100217.
    >> Share

  483. SALAMA C, Mohan SV
    Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. Reply.
    N Engl J Med. 2021 Mar 3. pii: 10.1056/NEJMc2100217.
    >> Share

  484. LUNDH A
    Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.
    N Engl J Med. 2021 Mar 3. pii: 10.1056/NEJMc2100217.
    >> Share

  485. LUDVIGSSON JF
    Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden. Reply.
    N Engl J Med. 2021 Mar 1. pii: 10.1056/NEJMc2101280.
    >> Share

  486. BESANCON L, Steadson D, Flahault A
    Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden.
    N Engl J Med. 2021 Mar 1. pii: 10.1056/NEJMc2101280.
    >> Share

  487. TAKEFUJI Y
    Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden.
    N Engl J Med. 2021 Mar 1. pii: 10.1056/NEJMc2101280.
    >> Share

    February 2021
  488. ROSAS IO, Brau N, Waters M, Go RC, et al
    Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.
    N Engl J Med. 2021 Feb 25. doi: 10.1056/NEJMoa2028700.
    >> Share

  489. GORDON AC, Mouncey PR, Al-Beidh F, Rowan KM, et al
    Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
    N Engl J Med. 2021 Feb 25. doi: 10.1056/NEJMoa2100433.
    >> Share

  490. RUBIN EJ, Longo DL, Baden LR
    Interleukin-6 Receptor Inhibition in Covid-19 - Cooling the Inflammatory Soup.
    N Engl J Med. 2021 Feb 25. doi: 10.1056/NEJMe2103108.
    >> Share

  491. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: The Real-World Effectiveness of Covid-19 Vaccination.
    N Engl J Med. 2021;384:e40.
    >> Share

  492. NORMAND ST
    The RECOVERY Platform.
    N Engl J Med. 2021;384:757-758.
    >> Share

  493. LANE HC, Fauci AS
    Research in the Context of a Pandemic.
    N Engl J Med. 2021;384:755-757.
    >> Share

  494. MEHROTRA A, Nimgaonkar A, Richman B
    Telemedicine and Medical Licensure - Potential Paths for Reform.
    N Engl J Med. 2021;384:687-690.
    >> Share

  495. VAIS S
    The Inequity of Isolation.
    N Engl J Med. 2021;384:690-691.
    >> Share

  496. DAGAN N, Barda N, Kepten E, Miron O, et al
    BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.
    N Engl J Med. 2021 Feb 24. doi: 10.1056/NEJMoa2101765.
    >> Share

  497. UBEL PA
    Vaccinating Health Care Employees - Do They All Deserve Early Access?
    N Engl J Med. 2021 Feb 19. doi: 10.1056/NEJMpv2101203.
    >> Share

  498. SHUREN J, Stenzel T
    The FDA's Experience with Covid-19 Antibody Tests.
    N Engl J Med. 2021;384:592-594.
    >> Share

  499. RUBIN EJ, Baden LR, Farrar JJ, Morrissey S, et al
    Audio Interview: Viral Variants and Covid-19.
    N Engl J Med. 2021;384:e38.
    >> Share

  500. SHRESTHA GS, Shrestha N, Lamsal R, Pradhan S, et al
    Emergency Intubation in Covid-19.
    N Engl J Med. 2021;384:e20.
    >> Share

  501. ABSALON J, Koury K, Gruber WC
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply.
    N Engl J Med. 2021;384.
    >> Share

  502. WANG X
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
    N Engl J Med. 2021;384.
    >> Share

  503. VERGNES JN
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
    N Engl J Med. 2021;384.
    >> Share

  504. SKOWRONSKI DM, De Serres G
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
    N Engl J Med. 2021;384.
    >> Share

  505. KADIRE SR, Wachter RM, Lurie N
    Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination.
    N Engl J Med. 2021 Feb 17. doi: 10.1056/NEJMclde2101987.
    >> Share

  506. HALLEY MC, Mangurian C
    Caring for the Caregivers - Covid-19 Vaccination for Essential Members of the Health Care Team.
    N Engl J Med. 2021 Feb 12. doi: 10.1056/NEJMpv2101339.
    >> Share

  507. ROSENBAUM L
    Escaping Catch-22 - Overcoming Covid Vaccine Hesitancy.
    N Engl J Med. 2021 Feb 12. doi: 10.1056/NEJMms2101220.
    >> Share

  508. HARRINGTON DP, Baden LR, Hogan JW
    A Large, Simple Trial Leading to Complex Questions.
    N Engl J Med. 2021;384:576-577.
    >> Share

  509. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Does Vaccination Mean the End of Masking and Social Distancing?
    N Engl J Med. 2021;384:e32.
    >> Share

  510. CASTELLS MC, Phillips EJ
    Maintaining Safety with SARS-CoV-2 Vaccines. Reply.
    N Engl J Med. 2021 Feb 10. pii: 10.1056/NEJMc2100766.
    >> Share

  511. ROLLA G, Brussino L, Badiu I
    Maintaining Safety with SARS-CoV-2 Vaccines.
    N Engl J Med. 2021 Feb 10. pii: 10.1056/NEJMc2100766.
    >> Share

  512. HORBY P, White NJ, Landray MJ
    Hydroxychloroquine in Hospitalized Patients with Covid-19. Reply.
    N Engl J Med. 2021;384.
    >> Share

  513. LACOUT A, Perronne C, Lounnas V
    Hydroxychloroquine in Hospitalized Patients with Covid-19.
    N Engl J Med. 2021;384.
    >> Share

  514. KASPER MR, Geibe JR
    An Outbreak of Covid-19 on an Aircraft Carrier. Reply.
    N Engl J Med. 2021;384.
    >> Share

  515. BYLICKI O, Paleiron N, Janvier F
    An Outbreak of Covid-19 on an Aircraft Carrier.
    N Engl J Med. 2021;384.
    >> Share

  516. RUBIN EJ, Baden LR, Northam RS, Morrissey S, et al
    Audio Interview: Covid-19 and the States - A Conversation with Ralph Northam.
    N Engl J Med. 2021;384:e25.
    >> Share

  517. GERBERDING JL, Haynes BF
    Vaccine Innovations - Past and Future.
    N Engl J Med. 2021;384:393-396.
    >> Share

  518. WYLLIE AL, Vogels CBF, Grubaugh ND
    Saliva for Detection of SARS-CoV-2. Reply.
    N Engl J Med. 2021;384.
    >> Share

  519. MARKEWITZ RDH, Wandinger KP, Junker R
    Saliva for Detection of SARS-CoV-2.
    N Engl J Med. 2021;384.
    >> Share

  520. LUNDGREN JD, Lane HC, Neaton JD
    Monoclonal Antibody for Patients with Covid-19. Reply.
    N Engl J Med. 2021 Feb 3. pii: 10.1056/NEJMc2100221.
    >> Share

  521. JAWORSKI JP
    Monoclonal Antibody for Patients with Covid-19.
    N Engl J Med. 2021 Feb 3. pii: 10.1056/NEJMc2100221.
    >> Share

    January 2021
  522. RUBIN EJ, Baden LR, Fauci AS, Morrissey S, et al
    Audio Interview: A Covid-19 Conversation with Anthony Fauci.
    N Engl J Med. 2021;384:e22.
    >> Share

  523. HEATON PM
    The Covid-19 Vaccine-Development Multiverse. Reply.
    N Engl J Med. 2021;384.
    >> Share

  524. KOJIMA N, Turner I, Klausner JD
    The Covid-19 Vaccine-Development Multiverse.
    N Engl J Med. 2021;384.
    >> Share

  525. KIM MC, Cui C, Shin KR, Bae JY, et al
    Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19.
    N Engl J Med. 2021 Jan 27. doi: 10.1056/NEJMc2027040.
    >> Share

  526. LEE TH, Chen AH
    Last-Mile Logistics of Covid Vaccination - The Role of Health Care Organizations.
    N Engl J Med. 2021 Jan 27. doi: 10.1056/NEJMp2100574.
    >> Share

  527. RUBIN EJ, Baden LR, Nottage K, O'Connell J, et al
    Audio Interview: An International Look at Covid-19.
    N Engl J Med. 2021;384:e19.
    >> Share

  528. COHEN MS
    Monoclonal Antibodies to Disrupt Progression of Early Covid-19 Infection.
    N Engl J Med. 2021;384:289-291.
    >> Share

  529. BOTTI-LODOVICO Y, Rosenberg E, Sabeti PC
    Testing in a Pandemic - Improving Access, Coordination, and Prioritization.
    N Engl J Med. 2021;384:197-199.
    >> Share

  530. PARMET WE
    Roman Catholic Diocese of Brooklyn v. Cuomo - The Supreme Court and Pandemic Controls.
    N Engl J Med. 2021;384:199-201.
    >> Share

  531. KLASS P, Ratner AJ
    Vaccinating Children against Covid-19 - The Lessons of Measles.
    N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMp2034765.
    >> Share

  532. VAN TASSEL K, Shachar C, Hoffman S
    Covid-19 Vaccine Injuries - Preventing Inequities in Compensation.
    N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMp2034438.
    >> Share

  533. HUGHES MT, Kahn J, Kachalia A
    Who Goes First? Government Leaders and Prioritization of SARS-CoV-2 Vaccines.
    N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMpv2036128.
    >> Share

  534. BAJAJ SS, Stanford FC
    Beyond Tuskegee - Vaccine Distrust and Everyday Racism.
    N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMpv2035827.
    >> Share

  535. RUBIN EJ, Baden LR, Abdool Karim SS, Morrissey S, et al
    Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant.
    N Engl J Med. 2021;384:e14.
    >> Share

  536. SADOFF J, Le Gars M, Shukarev G, Heerwegh D, et al
    Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.
    N Engl J Med. 2021 Jan 13. doi: 10.1056/NEJMoa2034201.
    >> Share

  537. KATZ LM
    (A Little) Clarity on Convalescent Plasma for Covid-19.
    N Engl J Med. 2021 Jan 13. doi: 10.1056/NEJMe2035678.
    >> Share

  538. JOYNER MJ, Carter RE, Senefeld JW, Klassen SA, et al
    Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19.
    N Engl J Med. 2021 Jan 13. doi: 10.1056/NEJMoa2031893.
    >> Share

  539. RUBIN EJ, Baden LR, Lee TH, Morrissey S, et al
    Audio Interview: Planning for the SARS-CoV-2 Vaccine Rollout.
    N Engl J Med. 2021;384:e13.
    >> Share

  540. LIBSTER R, Perez Marc G, Wappner D, Coviello S, et al
    Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults.
    N Engl J Med. 2021 Jan 6. doi: 10.1056/NEJMoa2033700.
    >> Share

  541. LUDVIGSSON JF, Engerstrom L, Nordenhall C, Larsson E, et al
    Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden.
    N Engl J Med. 2021 Jan 6. doi: 10.1056/NEJMc2026670.
    >> Share

  542. WOOD S, Schulman K
    Beyond Politics - Promoting Covid-19 Vaccination in the United States.
    N Engl J Med. 2021 Jan 6. doi: 10.1056/NEJMms2033790.
    >> Share

    December 2020
  543. ACKERMANN M, Mentzer SJ, Jonigk D
    Visualization of SARS-CoV-2 in the Lung. Reply.
    N Engl J Med. 2020;383:2689-2690.
    >> Share

  544. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A Look at Covid-19 Prevention and Care in 2020.
    N Engl J Med. 2020;383:e147.
    >> Share

  545. MILLER SE
    Visualization of SARS-CoV-2 in the Lung.
    N Engl J Med. 2020;383:2689.
    >> Share

  546. PERRIN JM, Kenney GM, Rosenbaum S
    Medicaid and Child Health Equity.
    N Engl J Med. 2020;383:2595-2598.
    >> Share

  547. CHATTERJEE P, Sommers BD, Joynt Maddox KE
    Essential but Undefined - Reimagining How Policymakers Identify Safety-Net Hospitals.
    N Engl J Med. 2020;383:2593-2595.
    >> Share

  548. RUBIN D, Chan-Tack K, Farley J, Sherwat A, et al
    FDA Approval of Remdesivir - A Step in the Right Direction.
    N Engl J Med. 2020;383:2598-2600.
    >> Share

  549. LEITER RE
    Reentry.
    N Engl J Med. 2020;383:e141.
    >> Share

  550. BADEN LR, Solomon CG, Greene MF, D'Agostino RB, et al
    The FDA and the Importance of Trust.
    N Engl J Med. 2020;383:e148.
    >> Share

  551. NIRULA A, Shen L, Skovronsky DM
    Neutralizing Antibody LY-CoV555 for Outpatient Covid-19. Reply.
    N Engl J Med. 2020;384.
    >> Share

  552. CASADEVALL A, Joyner MJ, Pirofski LA
    Neutralizing Antibody LY-CoV555 for Outpatient Covid-19.
    N Engl J Med. 2020;384.
    >> Share

  553. BADEN LR, El Sahly HM, Essink B, Kotloff K, et al
    Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
    N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMoa2035389.
    >> Share

  554. LEE MH, Perl DP, Nair G, Li W, et al
    Microvascular Injury in the Brains of Patients with Covid-19.
    N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMc2033369.
    >> Share

  555. HAYNES BF
    A New Vaccine to Battle Covid-19.
    N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMe2035557.
    >> Share

  556. FOPPIANO PALACIOS C, Travassos MA
    Vaccinating Detained Migrants against SARS-CoV-2 - Preventing Another Tragedy.
    N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMpv2035416.
    >> Share

  557. CASTELLS MC, Phillips EJ
    Maintaining Safety with SARS-CoV-2 Vaccines.
    N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMra2035343.
    >> Share

  558. BAROCAS JA
    Business Not as Usual - Covid-19 Vaccination in Persons with Substance Use Disorders.
    N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMpv2035709.
    >> Share

  559. HELLER HM, Gonzalez RG, Edlow BL, Ard KL, et al
    Case 40-2020: A 24-Year-Old Man with Headache and Covid-19.
    N Engl J Med. 2020;383:2572-2580.
    >> Share

  560. MAITRA A
    Holding Up.
    N Engl J Med. 2020;383:2498-2499.
    >> Share

  561. RITTENBERG E
    Sewing Masks - Resilience in the Face of Covid.
    N Engl J Med. 2020;383:2497-2498.
    >> Share

  562. TAMBYRAJA AL
    New Order, New Hope.
    N Engl J Med. 2020;383:2495-2496.
    >> Share

  563. LUMLEY SF, O'Donnell D, Stoesser NE, Matthews PC, et al
    Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.
    N Engl J Med. 2020 Dec 23. doi: 10.1056/NEJMoa2034545.
    >> Share

  564. LUNDGREN JD, Grund B, Barkauskas CE, Holland TL, et al
    A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
    N Engl J Med. 2020 Dec 22. doi: 10.1056/NEJMoa2033130.
    >> Share

  565. STONE JH, Horick NK, Healy BC
    Tocilizumab in Covid-19. Reply.
    N Engl J Med. 2020;384.
    >> Share

  566. LEAF DE, Gupta S, Wang W
    Tocilizumab in Covid-19.
    N Engl J Med. 2020;384.
    >> Share

  567. SALAMA C, Han J, Yau L, Reiss WG, et al
    Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.
    N Engl J Med. 2020 Dec 17. doi: 10.1056/NEJMoa2030340.
    >> Share

  568. WEINREICH DM, Sivapalasingam S, Norton T, Ali S, et al
    REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.
    N Engl J Med. 2020 Dec 17. doi: 10.1056/NEJMoa2035002.
    >> Share

  569. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19 Vaccine Fundamentals.
    N Engl J Med. 2020;383:e146.
    >> Share

  570. CHASTAIN DB, Henao-Martinez AF, Young HN
    Racial Disproportionality in Covid Clinical Trials. Reply.
    N Engl J Med. 2020;383:2488-2490.
    >> Share

  571. TOMASHEK KM, Mehta AK, Hynes NA
    Racial Disproportionality in Covid Clinical Trials.
    N Engl J Med. 2020;383:2487-2488.
    >> Share

  572. GOLDMAN JD, Osinusi A, Marty FM
    Racial Disproportionality in Covid Clinical Trials.
    N Engl J Med. 2020;383:2486-2487.
    >> Share

  573. HUNTER DJ
    Trying to "Protect the NHS" in the United Kingdom.
    N Engl J Med. 2020;383:e136.
    >> Share

  574. BARIC RS
    Emergence of a Highly Fit SARS-CoV-2 Variant.
    N Engl J Med. 2020 Dec 16. doi: 10.1056/NEJMcibr2032888.
    >> Share

  575. KALIL AC, Patterson TF, Mehta AK, Tomashek KM, et al
    Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
    N Engl J Med. 2020 Dec 11. doi: 10.1056/NEJMoa2031994.
    >> Share

  576. POLACK FP, Thomas SJ, Kitchin N, Absalon J, et al
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
    N Engl J Med. 2020 Dec 10. doi: 10.1056/NEJMoa2034577.
    >> Share

  577. RUBIN EJ, Longo DL
    SARS-CoV-2 Vaccination - An Ounce (Actually, Much Less) of Prevention.
    N Engl J Med. 2020 Dec 10. doi: 10.1056/NEJMe2034717.
    >> Share

  578. RUBIN EJ, Baden LR, Barocas JA, Morrissey S, et al
    Audio Interview: SARS-CoV-2 Vaccination and Vulnerable Populations.
    N Engl J Med. 2020;383:e143.
    >> Share

  579. HUANG E, Jordan SC
    Tocilizumab for Covid-19 - The Ongoing Search for Effective Therapies.
    N Engl J Med. 2020;383:2387-2388.
    >> Share

  580. LEICK MB
    Telephone.
    N Engl J Med. 2020;383:2304-2305.
    >> Share

  581. WIDGE AT, Rouphael NG, Jackson LA, Anderson EJ, et al
    Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.
    N Engl J Med. 2020 Dec 3. doi: 10.1056/NEJMc2032195.
    >> Share

  582. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Caring for Hospitalized Patients with Covid-19.
    N Engl J Med. 2020;383:e140.
    >> Share

  583. FAJGENBAUM DC, June CH
    Cytokine Storm.
    N Engl J Med. 2020;383:2255-2273.
    >> Share

  584. LAHEY T
    The Bottom of the Health Care Rationing Iceberg.
    N Engl J Med. 2020;383:2200-2201.
    >> Share

  585. XING Y, Wong GWK, Ni W, Hu X, et al
    Rapid Response to an Outbreak in Qingdao, China.
    N Engl J Med. 2020;383:e129.
    >> Share

  586. PAN H, Peto R, Henao-Restrepo AM, Preziosi MP, et al
    Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
    N Engl J Med. 2020 Dec 2. doi: 10.1056/NEJMoa2023184.
    >> Share

  587. KRAUSE PR, Fleming TR, Longini IM, Peto R, et al
    Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them.
    N Engl J Med. 2020 Dec 2. doi: 10.1056/NEJMp2033538.
    >> Share

  588. CAVALCANTI AB, Berwanger O, Zampieri FG
    Hydroxychloroquine with or without Azithromycin in Covid-19. Reply.
    N Engl J Med. 2020;383.
    >> Share

  589. CHOUDHARY R, Bohra GK, Kumar D
    Hydroxychloroquine with or without Azithromycin in Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  590. KEANE MJ
    Hydroxychloroquine with or without Azithromycin in Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  591. AYDILLO T, Gonzalez-Reiche AS, Aslam S, van de Guchte A, et al
    Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer.
    N Engl J Med. 2020 Dec 1. doi: 10.1056/NEJMc2031670.
    >> Share

    November 2020
  592. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: New Studies of Covid-19 Transmission.
    N Engl J Med. 2020;383:e138.
    >> Share

  593. SIMONOVICH VA, Burgos Pratx LD, Scibona P, Beruto MV, et al
    A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia.
    N Engl J Med. 2020 Nov 24. doi: 10.1056/NEJMoa2031304.
    >> Share

  594. MITJA O, Corbacho-Monne M, Ubals M, Alemany A, et al
    A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.
    N Engl J Med. 2020 Nov 24. doi: 10.1056/NEJMoa2021801.
    >> Share

  595. KATZ DH, Wilson JG, Gerszten RE
    Mining a GWAS of Severe Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  596. KARIM M, Ghoussaini M, Dunham I
    Mining a GWAS of Severe Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  597. KENNEDY BS, Richeson RP, Houde AJ
    Risk Factors for SARS-CoV-2 in a Statewide Correctional System.
    N Engl J Med. 2020 Nov 24. doi: 10.1056/NEJMc2029354.
    >> Share

  598. MANZANO GS, Woods JK, Amato AA
    Covid-19-Associated Myopathy Caused by Type I Interferonopathy.
    N Engl J Med. 2020 Nov 20. doi: 10.1056/NEJMc2031085.
    >> Share


  599. Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.
    N Engl J Med. 2020;383:e119.
    >> Share

  600. RUBIN EJ, Baden LR, Haug CJ, Morrissey S, et al
    Audio Interview: Covid-19 in Europe and New Information on Vaccines.
    N Engl J Med. 2020;383:e134.
    >> Share

  601. MALINA S, Warbelow S, Radix AE
    Two Steps Back - Rescinding Transgender Health Protections in Risky Times.
    N Engl J Med. 2020;383:e116.
    >> Share

  602. RUBIN EJ, Baden LR, Woodcock J, Morrissey S, et al
    Audio Interview: An Update from Operation Warp Speed.
    N Engl J Med. 2020;383:e127.
    >> Share

  603. LETIZIA AG, Ramos I, Obla A, Goforth C, et al
    SARS-CoV-2 Transmission among Marine Recruits during Quarantine.
    N Engl J Med. 2020 Nov 11. doi: 10.1056/NEJMoa2029717.
    >> Share

  604. CHOI B, Choudhary MC, Regan J, Sparks JA, et al
    Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host.
    N Engl J Med. 2020 Nov 11. doi: 10.1056/NEJMc2031364.
    >> Share

  605. KASPER MR, Geibe JR, Sears CL, Riegodedios AJ, et al
    An Outbreak of Covid-19 on an Aircraft Carrier.
    N Engl J Med. 2020 Nov 11. doi: 10.1056/NEJMoa2019375.
    >> Share

  606. MICHAEL NL
    SARS-CoV-2 in the U.S. Military - Lessons for Civil Society.
    N Engl J Med. 2020 Nov 11. doi: 10.1056/NEJMe2032179.
    >> Share

  607. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: What the U.S. Response to Covid-19 Looks Like Today.
    N Engl J Med. 2020;383:e123.
    >> Share

  608. DOLIN R, Hirsch MS
    Remdesivir - An Important First Step.
    N Engl J Med. 2020;383:1886-1887.
    >> Share

  609. MATIAS WR, Vaidya A, Brigl M, Bebell LM, et al
    A Patient with Fever and Dyspnea.
    N Engl J Med. 2020;383:e111.
    >> Share

  610. GUDBJARTSSON DF, Stefansson K
    Early Spread of SARS-CoV-2 in the Icelandic Population. Reply.
    N Engl J Med. 2020;383.
    >> Share

  611. COWIE BC, MacLachlan JH
    Early Spread of SARS-CoV-2 in the Icelandic Population.
    N Engl J Med. 2020;383.
    >> Share

    October 2020
  612. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New Monoclonal Antibody for Covid-19.
    N Engl J Med. 2020;383:e117.
    >> Share

  613. WU K, Smith CR, Lembcke BT, Ferreira TBD, et al
    Elective Surgery during the Covid-19 Pandemic.
    N Engl J Med. 2020;383:1787-1790.
    >> Share

  614. LEVIN M
    Multisystem Inflammatory Syndrome in Children in the United States. Reply.
    N Engl J Med. 2020;383:1795-1796.
    >> Share

  615. FELDSTEIN LR, Rose EB, Randolph AG
    Multisystem Inflammatory Syndrome in Children in the United States. Reply.
    N Engl J Med. 2020;383:1794-1795.
    >> Share

  616. ARDITI M, Bahar I
    Multisystem Inflammatory Syndrome in Children in the United States.
    N Engl J Med. 2020;383:1794.
    >> Share

  617. ALTER G, Seder R
    The Power of Antibody-Based Surveillance.
    N Engl J Med. 2020;383:1782-1784.
    >> Share

  618. BLENDON RJ, Benson JM
    Implications of the 2020 Election for U.S. Health Policy.
    N Engl J Med. 2020;383:e105.
    >> Share

  619. CAHAN EM, Levine LB, Chin WW
    The Human Touch - Addressing Health Care's Workforce Problem amid the Pandemic.
    N Engl J Med. 2020;383:e102.
    >> Share

  620. DEFOREST A
    The New Stability.
    N Engl J Med. 2020;383:1708-1709.
    >> Share

  621. HALABI S, Heinrich A, Omer SB
    No-Fault Compensation for Vaccine Injury - The Other Side of Equitable Access to Covid-19 Vaccines.
    N Engl J Med. 2020 Oct 28. doi: 10.1056/NEJMp2030600.
    >> Share

  622. CHEN P, Nirula A, Heller B, Gottlieb RL, et al
    SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.
    N Engl J Med. 2020 Oct 28. doi: 10.1056/NEJMoa2029849.
    >> Share

  623. REYNOLDS HR, Adhikari S, Iturrate E
    RAAS Inhibitors and Risk of Covid-19. Reply.
    N Engl J Med. 2020;383.
    >> Share

  624. MANCIA G, Rea F, Corrao G
    RAAS Inhibitors and Risk of Covid-19. Reply.
    N Engl J Med. 2020;383.
    >> Share

  625. STRAUSS MH, Hall AS, Lavie CJ
    RAAS Inhibitors and Risk of Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  626. ISLAM N, Khunti K, Chowell G
    RAAS Inhibitors and Risk of Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  627. SRIRAM K, Loomba R, Insel PA
    RAAS Inhibitors and Risk of Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  628. ANGELI F, Verdecchia P, Reboldi G
    RAAS Inhibitors and Risk of Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  629. GANDHI M, Rutherford GW
    Facial Masking for Covid-19. Reply.
    N Engl J Med. 2020;383.
    >> Share

  630. BROSSEAU LM, Roy CJ, Osterholm MT
    Facial Masking for Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  631. RASMUSSEN AL, Escandon K, Popescu SV
    Facial Masking for Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  632. PLATTON S, Bowles L, Pasi KJ
    Lupus Anticoagulant in Patients with Covid-19. Reply.
    N Engl J Med. 2020;383.
    >> Share

  633. GOODING R, Myers B, Salta S
    Lupus Anticoagulant in Patients with Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  634. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Tocilizumab and Covid-19.
    N Engl J Med. 2020;383:e114.
    >> Share

  635. CHOWDHURY JF, Moores LK, Connors JM
    Anticoagulation in Hospitalized Patients with Covid-19.
    N Engl J Med. 2020;383:1675-1678.
    >> Share

  636. ROSENBAUM L
    Tribal Truce - How Can We Bridge the Partisan Divide and Conquer Covid?
    N Engl J Med. 2020;383:1682-1685.
    >> Share

  637. WILENSKY GR
    Policy Lessons from Our Covid Experience.
    N Engl J Med. 2020;383:e96.
    >> Share

  638. AGARWAL SD, Sommers BD
    Insurance Coverage after Job Loss - The Importance of the ACA during the Covid-Associated Recession.
    N Engl J Med. 2020;383:1603-1606.
    >> Share

  639. STRASSLE C, Jardas E, Ochoa J, Berkman BE, et al
    Covid-19 Vaccine Trials and Incarcerated People - The Ethics of Inclusion.
    N Engl J Med. 2020 Oct 21. doi: 10.1056/NEJMp2025955.
    >> Share

  640. STONE JH, Frigault MJ, Serling-Boyd NJ, Fernandes AD, et al
    Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.
    N Engl J Med. 2020 Oct 21. doi: 10.1056/NEJMoa2028836.
    >> Share

  641. RAFIEI Y, Mello MM
    The Missing Piece - SARS-CoV-2 Testing and School Reopening.
    N Engl J Med. 2020 Oct 21. doi: 10.1056/NEJMp2028209.
    >> Share

  642. BELOT A, Levy-Bruhl D
    Multisystem Inflammatory Syndrome in Children in the United States.
    N Engl J Med. 2020;383.
    >> Share

  643. WARREN RC, Forrow L, Hodge DA Sr, Truog RD, et al
    Trustworthiness before Trust - Covid-19 Vaccine Trials and the Black Community.
    N Engl J Med. 2020 Oct 16. doi: 10.1056/NEJMp2030033.
    >> Share

  644. KRAUSE PR, Gruber MF
    Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up Considerations.
    N Engl J Med. 2020 Oct 16. doi: 10.1056/NEJMp2031373.
    >> Share

  645. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Vaccinology and Covid-19.
    N Engl J Med. 2020;383:e109.
    >> Share

  646. KASER A
    Genetic Risk of Severe Covid-19.
    N Engl J Med. 2020;383:1590-1591.
    >> Share

  647. GLIED S
    Health Policy in a Biden Administration.
    N Engl J Med. 2020;383:1501-1503.
    >> Share

  648. WALSH EE, Frenck RW Jr, Falsey AR, Kitchin N, et al
    Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
    N Engl J Med. 2020 Oct 14. doi: 10.1056/NEJMoa2027906.
    >> Share

  649. SHAPIRO J, McDonald TB
    Supporting Clinicians during Covid-19 and Beyond - Learning from Past Failures and Envisioning New Strategies.
    N Engl J Med. 2020 Oct 14. doi: 10.1056/NEJMp2024834.
    >> Share

  650. HORBY P, Mafham M, Linsell L, Bell JL, et al
    Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
    N Engl J Med. 2020 Oct 8. doi: 10.1056/NEJMoa2022926.
    >> Share

  651. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19 and the President.
    N Engl J Med. 2020;383:e104.
    >> Share


  652. Dying in a Leadership Vacuum.
    N Engl J Med. 2020;383:1479-1480.
    >> Share

  653. PAGE KR, Flores-Miller A
    Lessons We've Learned - Covid-19 and the Undocumented Latinx Community.
    N Engl J Med. 2020 Oct 7. doi: 10.1056/NEJMp2024897.
    >> Share

  654. CELUM C, Barnabas R, Cohen MS, Collier A, et al
    Covid-19, Ebola, and HIV - Leveraging Lessons to Maximize Impact.
    N Engl J Med. 2020 Oct 7. doi: 10.1056/NEJMp2022269.
    >> Share

  655. ROSENQUIST JN
    The Stress of Bayesian Medicine - Uncomfortable Uncertainty in the Face of Covid-19.
    N Engl J Med. 2020 Oct 7. doi: 10.1056/NEJMp2018857.
    >> Share

  656. ARABI YM, Asiri AY, Assiri AM, Balkhy HH, et al
    Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory Syndrome.
    N Engl J Med. 2020 Oct 7. doi: 10.1056/NEJMoa2015294.
    >> Share

  657. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19 Testing and the Individual Physician.
    N Engl J Med. 2020;383:e99.
    >> Share

  658. HATA SR
    The Ritual of the Table.
    N Engl J Med. 2020;383:1301-1303.
    >> Share

    September 2020
  659. RASMUSSEN SA, Lyerly AD, Jamieson DJ
    Delaying Pregnancy during a Public Health Crisis - Examining Public Health Recommendations for Covid-19 and Beyond.
    N Engl J Med. 2020 Sep 30. doi: 10.1056/NEJMp2027940.
    >> Share

  660. MINA MJ, Parker R, Larremore DB
    Rethinking Covid-19 Test Sensitivity - A Strategy for Containment.
    N Engl J Med. 2020 Sep 30. doi: 10.1056/NEJMp2025631.
    >> Share

  661. ANDERSON EJ, Rouphael NG, Widge AT, Jackson LA, et al
    Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.
    N Engl J Med. 2020 Sep 29. doi: 10.1056/NEJMoa2028436.
    >> Share

  662. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Eight Months of Action and Inaction against Covid-19.
    N Engl J Med. 2020;383:e95.
    >> Share

  663. CHRISTIE A, Neatherlin JC, Nichol ST, Beach M, et al
    Ebola Response Priorities in the Time of Covid-19.
    N Engl J Med. 2020;383:1202-1204.
    >> Share

  664. CUNEO CN, Janeway H
    From Icebox to Tinderbox - A View from the Southern Border.
    N Engl J Med. 2020;383:e81.
    >> Share

  665. SCHWARTZ JL
    Evaluating and Deploying Covid-19 Vaccines - The Importance of Transparency, Scientific Integrity, and Public Trust.
    N Engl J Med. 2020 Sep 23. doi: 10.1056/NEJMp2026393.
    >> Share

  666. PERETZ PJ, Islam N, Matiz LA
    Community Health Workers and Covid-19 - Addressing Social Determinants of Health in Times of Crisis and Beyond.
    N Engl J Med. 2020 Sep 23. doi: 10.1056/NEJMp2022641.
    >> Share

  667. YANG OO, Ibarrondo FJ
    Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19. Reply.
    N Engl J Med. 2020;383.
    >> Share

  668. KUTSUNA S, Asai Y, Matsunaga A
    Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  669. TERPOS E, Mentis A, Dimopoulos MA
    Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  670. BOLKE E, Matuschek C, Fischer JC
    Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  671. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Operation Warp Speed and Covid-19 Therapeutics.
    N Engl J Med. 2020;383:e92.
    >> Share

  672. FISHMAN JA, Roberts MB, Zhang EW, Kumar D, et al
    Case 29-2020: A 66-Year-Old Man with Fever and Shortness of Breath after Liver Transplantation.
    N Engl J Med. 2020;383:1168-1180.
    >> Share

  673. EVANS ML, Lindauer M, Farrell ME
    A Pandemic within a Pandemic - Intimate Partner Violence during Covid-19.
    N Engl J Med. 2020 Sep 16. doi: 10.1056/NEJMp2024046.
    >> Share

  674. JOUNG J, Ladha A, Saito M, Kim NG, et al
    Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing.
    N Engl J Med. 2020 Sep 16. doi: 10.1056/NEJMc2026172.
    >> Share

  675. SLAOUI M, Greene SE, Woodcock J
    Bridging the Gap at Warp Speed - Delivering Options for Preventing and Treating Covid-19.
    N Engl J Med. 2020 Sep 15. doi: 10.1056/NEJMp2028535.
    >> Share

  676. AVORN J, Kesselheim AS
    Up Is Down - Pharmaceutical Industry Caution vs. Federal Acceleration of Covid-19 Vaccine Approval.
    N Engl J Med. 2020 Sep 15. doi: 10.1056/NEJMp2029479.
    >> Share

  677. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Guidelines for Covid-19 Vaccine Deployment.
    N Engl J Med. 2020;383:e88.
    >> Share

  678. MANTOVANI A, Netea MG
    Trained Innate Immunity, Epigenetics, and Covid-19.
    N Engl J Med. 2020;383:1078-1080.
    >> Share

  679. EVANS MK
    Health Equity - Are We Finally on the Edge of a New Frontier?
    N Engl J Med. 2020;383:997-999.
    >> Share

  680. GOLDHAMER MEJ, Pusic MV, Co JPT, Weinstein DF, et al
    Can Covid Catalyze an Educational Transformation? Competency-Based Advancement in a Crisis.
    N Engl J Med. 2020;383:1003-1005.
    >> Share

  681. SHUREN J, Stenzel T
    Covid-19 Molecular Diagnostic Testing - Lessons Learned.
    N Engl J Med. 2020 Sep 9. doi: 10.1056/NEJMp2023830.
    >> Share

  682. GANDHI M, Rutherford GW
    Facial Masking for Covid-19 - Potential for "Variolation" as We Await a Vaccine.
    N Engl J Med. 2020 Sep 8. doi: 10.1056/NEJMp2026913.
    >> Share

  683. BLOOM BR, Nowak GJ, Orenstein W
    "When Will We Have a Vaccine?" - Understanding Questions and Answers about Covid-19 Vaccination.
    N Engl J Med. 2020 Sep 8. doi: 10.1056/NEJMp2025331.
    >> Share

  684. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Understanding Antibody Testing in Covid-19.
    N Engl J Med. 2020;383:e85.
    >> Share

  685. EHRE C
    SARS-CoV-2 Infection of Airway Cells.
    N Engl J Med. 2020;383:969.
    >> Share

  686. LEVINSON M, Cevik M, Lipsitch M
    Reopening Primary Schools during the Pandemic.
    N Engl J Med. 2020;383:981-985.
    >> Share

  687. EARNEST M
    On Becoming a Plague Doctor.
    N Engl J Med. 2020;383:e64.
    >> Share

  688. KEECH C, Albert G, Cho I, Robertson A, et al
    Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.
    N Engl J Med. 2020 Sep 2. doi: 10.1056/NEJMoa2026920.
    >> Share

  689. GUDBJARTSSON DF, Norddahl GL, Melsted P, Gunnarsdottir K, et al
    Humoral Immune Response to SARS-CoV-2 in Iceland.
    N Engl J Med. 2020 Sep 1. doi: 10.1056/NEJMoa2026116.
    >> Share

    August 2020
  690. WYLLIE AL, Fournier J, Casanovas-Massana A, Campbell M, et al
    Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2.
    N Engl J Med. 2020 Aug 28. doi: 10.1056/NEJMc2016359.
    >> Share

  691. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Operation Warp Speed and Covid-19.
    N Engl J Med. 2020;383:e79.
    >> Share

  692. CHASTAIN DB, Osae SP, Henao-Martinez AF, Franco-Paredes C, et al
    Racial Disproportionality in Covid Clinical Trials.
    N Engl J Med. 2020;383:e59.
    >> Share

  693. SLAOUI M, Hepburn M
    Developing Safe and Effective Covid Vaccines - Operation Warp Speed's Strategy and Approach.
    N Engl J Med. 2020 Aug 26. doi: 10.1056/NEJMp2027405.
    >> Share

  694. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19 and Contact Tracing.
    N Engl J Med. 2020;383:e73.
    >> Share

  695. SINGHAL AB, Gonzalez RG, Chwalisz BK, Mukerji SS, et al
    Case 26-2020: A 60-Year-Old Woman with Altered Mental Status and Weakness on the Left Side.
    N Engl J Med. 2020;383:764-773.
    >> Share

  696. GUPTA A
    Plans and Pandemics.
    N Engl J Med. 2020;383:e53.
    >> Share

  697. BARNES M, Sax PE
    Challenges of "Return to Work" in an Ongoing Pandemic.
    N Engl J Med. 2020;383:779-786.
    >> Share

  698. JACKSON LA, Roberts PC, Graham BS
    A SARS-CoV-2 mRNA Vaccine - Preliminary Report. Reply.
    N Engl J Med. 2020;383.
    >> Share

  699. SCHAEFER JR, Sharkova Y, Nickolaus T
    A SARS-CoV-2 mRNA Vaccine - Preliminary Report.
    N Engl J Med. 2020;383.
    >> Share

  700. SCHACHAR RA, Schachar IH
    A SARS-CoV-2 mRNA Vaccine - Preliminary Report.
    N Engl J Med. 2020;383.
    >> Share

  701. CHEN L, Zhao Y, Qiao J
    More on Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China. Reply.
    N Engl J Med. 2020;383:697.
    >> Share

  702. VOUGA M, Grobman WA, Baud D
    More on Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China.
    N Engl J Med. 2020;383:696-697.
    >> Share

  703. MOFENSON LM, Ciaranello A, LaHood N
    More on Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China.
    N Engl J Med. 2020;383:696.
    >> Share

  704. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Building a Successful Public Health Response to Covid-19.
    N Engl J Med. 2020;383:e67.
    >> Share

  705. SHARMA A, Eisen JE, Shepard JO, Bernheim A, et al
    Case 25-2020: A 47-Year-Old Woman with a Lung Mass.
    N Engl J Med. 2020;383:665-674.
    >> Share

  706. BLOOM BR, Farmer PE, Rubin EJ
    WHO's Next - The United States and the World Health Organization.
    N Engl J Med. 2020;383:676-677.
    >> Share

  707. STUART JC
    Making the Call.
    N Engl J Med. 2020;383:e46.
    >> Share

  708. BARR J, Podolsky SH
    A National Medical Response to Crisis - The Legacy of World War II.
    N Engl J Med. 2020;383:613-615.
    >> Share

  709. HORN DM, Haas JS
    Covid-19 and the Mandate to Redefine Preventive Care.
    N Engl J Med. 2020 Aug 12. doi: 10.1056/NEJMp2018749.
    >> Share

  710. BAKER MG, Wilson N, Anglemyer A
    Successful Elimination of Covid-19 Transmission in New Zealand.
    N Engl J Med. 2020 Aug 7. doi: 10.1056/NEJMc2025203.
    >> Share

  711. RUBIN EJ, Baden LR, Epstein A, Morrissey S, et al
    Audio Interview: The Impact of Covid-19 on Patients with Other Diseases, with Arnold Epstein.
    N Engl J Med. 2020;383:e62.
    >> Share

  712. PFEFFERBAUM B, North CS
    Mental Health and the Covid-19 Pandemic.
    N Engl J Med. 2020;383:510-512.
    >> Share

  713. MACKENZIE OW, Trimbur MC, Vanjani R
    An Isolation Hotel for People Experiencing Homelessness.
    N Engl J Med. 2020;383:e41.
    >> Share

  714. BEACH SL
    Of Heroes and Cowards.
    N Engl J Med. 2020;383:e36.
    >> Share

  715. BRENER MI, Kaslow SR
    Where Do the Children Play?
    N Engl J Med. 2020;383:e35.
    >> Share

  716. DZAU VJ, Kirch D, Nasca T
    Preventing a Parallel Pandemic - A National Strategy to Protect Clinicians' Well-Being.
    N Engl J Med. 2020;383:513-515.
    >> Share

  717. STUDDERT DM, Hall MA, Mello MM
    Partitioning the Curve - Interstate Travel Restrictions During the Covid-19 Pandemic.
    N Engl J Med. 2020 Aug 5. doi: 10.1056/NEJMp2024274.
    >> Share

    July 2020
  718. RUBIN EJ, Baden LR, Piot P, Morrissey S, et al
    Audio Interview: New SARS-CoV-2 Vaccine Results, with Peter Piot.
    N Engl J Med. 2020;383:e57.
    >> Share

  719. EVANS MK
    Covid's Color Line - Infectious Disease, Inequity, and Racial Justice.
    N Engl J Med. 2020;383:408-410.
    >> Share

  720. HALL MA, Mello MM, Studdert DM
    The Legal Authority for States' Stay-at-Home Orders.
    N Engl J Med. 2020;383:e29.
    >> Share

  721. RASMUSSEN SA, Jamieson DJ
    Public Health Decision Making during Covid-19 - Fulfilling the CDC Pledge to the American People.
    N Engl J Med. 2020 Jul 29. doi: 10.1056/NEJMp2026045.
    >> Share

  722. CORBETT KS, Flynn B, Foulds KE, Francica JR, et al
    Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.
    N Engl J Med. 2020 Jul 28. doi: 10.1056/NEJMoa2024671.
    >> Share


  723. Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.
    N Engl J Med. 2020 Jul 23. doi: 10.1056/NEJMx200017.
    >> Share


  724. Covid-19 - Implications for the Health Care System.
    N Engl J Med. 2020 Jul 23. doi: 10.1056/NEJMx200018.
    >> Share

  725. CAVALCANTI AB, Zampieri FG, Rosa RG, Azevedo LCP, et al
    Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.
    N Engl J Med. 2020 Jul 23. doi: 10.1056/NEJMoa2019014.
    >> Share

  726. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Dexamethasone and Covid-19.
    N Engl J Med. 2020;383:e52.
    >> Share

  727. LEVIN M
    Childhood Multisystem Inflammatory Syndrome - A New Challenge in the Pandemic.
    N Engl J Med. 2020;383:393-395.
    >> Share

  728. AWDISH RLA
    The Liminal Space.
    N Engl J Med. 2020;383:e17.
    >> Share

  729. DELIMA THOMAS J
    Pandemic as Teacher - Forcing Clinicians to Inhabit the Experience of Serious Illness.
    N Engl J Med. 2020;383:306-307.
    >> Share

  730. SCHNEIDER EC
    Failing the Test - The Tragic Data Gap Undermining the U.S. Pandemic Response.
    N Engl J Med. 2020;383:299-302.
    >> Share

  731. CLEVELAND MANCHANDA E, Couillard C, Sivashanker K
    Inequity in Crisis Standards of Care.
    N Engl J Med. 2020;383:e16.
    >> Share

  732. TROMBERG BJ, Schwetz TA, Perez-Stable EJ, Hodes RJ, et al
    Rapid Scaling Up of Covid-19 Diagnostic Testing in the United States - The NIH RADx Initiative.
    N Engl J Med. 2020 Jul 22. doi: 10.1056/NEJMsr2022263.
    >> Share

  733. BLUMENTHAL D, Fowler EJ, Abrams M, Collins SR, et al
    Covid-19 - Implications for the Health Care System.
    N Engl J Med. 2020 Jul 22. doi: 10.1056/NEJMsb2021088.
    >> Share

  734. BERKOWITZ SA, Cene CW, Chatterjee A
    Covid-19 and Health Equity - Time to Think Big.
    N Engl J Med. 2020 Jul 22. doi: 10.1056/NEJMp2021209.
    >> Share

  735. EGEDE LE, Walker RJ
    Structural Racism, Social Risk Factors, and Covid-19 - A Dangerous Convergence for Black Americans.
    N Engl J Med. 2020 Jul 22. doi: 10.1056/NEJMp2023616.
    >> Share

  736. IBARRONDO FJ, Fulcher JA, Goodman-Meza D, Elliott J, et al
    Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.
    N Engl J Med. 2020 Jul 21. doi: 10.1056/NEJMc2025179.
    >> Share

  737. ACKERMANN M, Mentzer SJ, Jonigk D
    Pulmonary Vascular Pathology in Covid-19. Reply.
    N Engl J Med. 2020;383.
    >> Share

  738. SCHOLKMANN F, Nicholls J
    Pulmonary Vascular Pathology in Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  739. SOM A, Lang M, Little B
    Pulmonary Vascular Pathology in Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  740. BUREL-VANDENBOS F, Cardot-Leccia N, Passeron T
    Pulmonary Vascular Pathology in Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  741. HORBY P, Lim WS, Emberson JR, Mafham M, et al
    Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report.
    N Engl J Med. 2020 Jul 17. doi: 10.1056/NEJMoa2021436.
    >> Share

  742. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19 Vaccine Development.
    N Engl J Med. 2020;383:e40.
    >> Share

  743. CLOSE RM, Stone MJ
    Contact Tracing for Native Americans in Rural Arizona.
    N Engl J Med. 2020;383:e15.
    >> Share

  744. HARDEMAN RR, Medina EM, Boyd RW
    Stolen Breaths.
    N Engl J Med. 2020;383:197-199.
    >> Share

  745. NORTH CM, Dougan ML, Sacks CA
    Improving Clinical Trial Enrollment - In the Covid-19 Era and Beyond.
    N Engl J Med. 2020 Jul 15. doi: 10.1056/NEJMp2019989.
    >> Share

  746. SALAS RN, Shultz JM, Solomon CG
    The Climate Crisis and Covid-19 - A Major Threat to the Pandemic Response.
    N Engl J Med. 2020 Jul 15. doi: 10.1056/NEJMp2022011.
    >> Share

  747. OKAFOR EC, Pastick KA, Rajasingham R
    Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Reply.
    N Engl J Med. 2020;383.
    >> Share

  748. TEKWANI BL
    Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  749. KHAN MS, Butler J
    Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  750. AVIDAN MS, Dehbi HM, Delany-Moretlwe S
    Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  751. BELANGER MJ, Hill MA, Angelidi AM, Dalamaga M, et al
    Covid-19 and Disparities in Nutrition and Obesity.
    N Engl J Med. 2020 Jul 15. doi: 10.1056/NEJMp2021264.
    >> Share

  752. NEWTON-CHEH C, Zlotoff DA, Hung J, Rupasov A, et al
    Case 24-2020: A 44-Year-Old Woman with Chest Pain, Dyspnea, and Shock.
    N Engl J Med. 2020 Jul 15. doi: 10.1056/NEJMcpc2004975.
    >> Share

  753. JACKSON LA, Anderson EJ, Rouphael NG, Roberts PC, et al
    An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.
    N Engl J Med. 2020 Jul 14. doi: 10.1056/NEJMoa2022483.
    >> Share

  754. HEATON PM
    The Covid-19 Vaccine-Development Multiverse.
    N Engl J Med. 2020 Jul 14. doi: 10.1056/NEJMe2025111.
    >> Share

  755. BEIGEL JH, Tomashek KM, Dodd LE
    Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.
    N Engl J Med. 2020;383.
    >> Share

  756. OLALLA J
    Remdesivir for the Treatment of Covid-19 - Preliminary Report.
    N Engl J Med. 2020;383.
    >> Share

  757. MCCAW ZR, Kim DH, Wei LJ
    Remdesivir for the Treatment of Covid-19 - Preliminary Report.
    N Engl J Med. 2020;383.
    >> Share

  758. MCMAHON JH, Udy A, Peleg AY
    Remdesivir for the Treatment of Covid-19 - Preliminary Report.
    N Engl J Med. 2020;383.
    >> Share

  759. GILLENWATER S, Rahaghi F, Hadeh A
    Remdesivir for the Treatment of Covid-19 - Preliminary Report.
    N Engl J Med. 2020;383.
    >> Share

  760. HABERMAN RH, Adhikari S, Scher JU
    More on Covid-19 in Immune-Mediated Inflammatory Diseases. Reply.
    N Engl J Med. 2020;383.
    >> Share

  761. BRIGGS FBS, Gianfrancesco MA, George MF
    More on Covid-19 in Immune-Mediated Inflammatory Diseases.
    N Engl J Med. 2020;383.
    >> Share

  762. PEYRIN-BIROULET L, Danese S
    More on Covid-19 in Immune-Mediated Inflammatory Diseases.
    N Engl J Med. 2020;383.
    >> Share

  763. NALDI L, Cazzaniga S
    More on Covid-19 in Immune-Mediated Inflammatory Diseases.
    N Engl J Med. 2020;383.
    >> Share

  764. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Acute Lung Injury in Covid-19.
    N Engl J Med. 2020;383:e32.
    >> Share

  765. ROSENBAUM L
    Once Upon a Time...the Hero Sheltered in Place.
    N Engl J Med. 2020;383:e5.
    >> Share

  766. KOVICH H
    Rural Matters - Coronavirus and the Navajo Nation.
    N Engl J Med. 2020;383:105-107.
    >> Share

  767. STONE JR, Tran KM, Conklin J, Mino-Kenudson M, et al
    Case 23-2020: A 76-Year-Old Woman Who Died from Covid-19.
    N Engl J Med. 2020 Jul 8. doi: 10.1056/NEJMcpc2004974.
    >> Share

  768. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A Covid-19-Related Syndrome in Children.
    N Engl J Med. 2020;383:e10.
    >> Share

  769. ROUZIER V, Liautaud B, Deschamps MM
    Facing the Monster in Haiti.
    N Engl J Med. 2020;383:e4.
    >> Share

  770. KAHN MW
    Pandemic and Persona.
    N Engl J Med. 2020;383:e1.
    >> Share

  771. ARONSON L
    Age, Complexity, and Crisis - A Prescription for Progress in Pandemic.
    N Engl J Med. 2020;383:4-6.
    >> Share

  772. SPRING LM, Specht MC, Jimenez RB, Isakoff SJ, et al
    Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic.
    N Engl J Med. 2020 Jul 1. doi: 10.1056/NEJMcpc2002422.
    >> Share

  773. DEMING ME, Michael NL, Robb M, Cohen MS, et al
    Accelerating Development of SARS-CoV-2 Vaccines - The Role for Controlled Human Infection Models.
    N Engl J Med. 2020 Jul 1. doi: 10.1056/NEJMp2020076.
    >> Share

    June 2020
  774. FELDSTEIN LR, Rose EB, Horwitz SM, Collins JP, et al
    Multisystem Inflammatory Syndrome in U.S. Children and Adolescents.
    N Engl J Med. 2020 Jun 29. doi: 10.1056/NEJMoa2021680.
    >> Share

  775. DUFORT EM, Koumans EH, Chow EJ, Rosenthal EM, et al
    Multisystem Inflammatory Syndrome in Children in New York State.
    N Engl J Med. 2020 Jun 29. doi: 10.1056/NEJMoa2021756.
    >> Share

  776. NOZARI A, Ortega R, Gonzalez M
    Personal Protective Equipment and Covid-19. Reply.
    N Engl J Med. 2020;383.
    >> Share

  777. MA WH, Wang Y
    Personal Protective Equipment and Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  778. LIN Y, He Y
    Personal Protective Equipment and Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  779. KISHORE S, Hayden M
    Community Health Centers and Covid-19 - Time for Congress to Act.
    N Engl J Med. 2020 Jun 26. doi: 10.1056/NEJMp2020576.
    >> Share

  780. MELLO MM, Silverman RD, Omer SB
    Ensuring Uptake of Vaccines against SARS-CoV-2.
    N Engl J Med. 2020 Jun 26. doi: 10.1056/NEJMp2020926.
    >> Share

  781. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: The Challenges of Safe Reopening.
    N Engl J Med. 2020;382:e113.
    >> Share

  782. HARTZBAND P, Groopman J
    Physician Burnout, Interrupted.
    N Engl J Med. 2020;382:2485-2487.
    >> Share

  783. GAETA JM, De Las Nueces D, Munson DG, Barocas JA, et al
    Case 21-2020: A 66-Year-Old Homeless Man with Covid-19.
    N Engl J Med. 2020 Jun 24. doi: 10.1056/NEJMcpc2002421.
    >> Share

  784. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A Look at SARS-CoV-2 Transmission.
    N Engl J Med. 2020;382:e112.
    >> Share

  785. FULLER DH, Berglund P
    Amplifying RNA Vaccine Development.
    N Engl J Med. 2020;382:2469-2471.
    >> Share

  786. JACOBSEN JC, Tran KM, Jackson VA, Rubin EB, et al
    Case 19-2020: A 74-Year-Old Man with Acute Respiratory Failure and Unclear Goals of Care.
    N Engl J Med. 2020;382:2450-2457.
    >> Share

  787. ELLINGHAUS D, Degenhardt F, Bujanda L, Buti M, et al
    Genomewide Association Study of Severe Covid-19 with Respiratory Failure.
    N Engl J Med. 2020 Jun 17. doi: 10.1056/NEJMoa2020283.
    >> Share

  788. RUBINO F, Amiel SA, Zimmet P, Alberti G, et al
    New-Onset Diabetes in Covid-19.
    N Engl J Med. 2020 Jun 12. doi: 10.1056/NEJMc2018688.
    >> Share

  789. SAKURAI A, Sasaki T, Kato S, Hayashi M, et al
    Natural History of Asymptomatic SARS-CoV-2 Infection.
    N Engl J Med. 2020 Jun 12. doi: 10.1056/NEJMc2013020.
    >> Share

  790. SOLOMON IH, Normandin E, Bhattacharyya S, Mukerji SS, et al
    Neuropathological Features of Covid-19.
    N Engl J Med. 2020 Jun 12. doi: 10.1056/NEJMc2019373.
    >> Share

  791. RUBIN EJ, Baden LR, Evans M, Morrissey S, et al
    Audio Interview: The Impact of Covid-19 on Minority Communities.
    N Engl J Med. 2020;382:e111.
    >> Share

  792. KAZI DS, Martin LM, Litmanovich D, Pinto DS, et al
    Case 18-2020: A 73-Year-Old Man with Hypoxemic Respiratory Failure and Cardiac Dysfunction.
    N Engl J Med. 2020;382:2354-2364.
    >> Share

  793. ABDOOL KARIM SS
    The South African Response to the Pandemic.
    N Engl J Med. 2020;382:e95.
    >> Share

  794. JAYAWARDENA A
    Waiting for Something Positive.
    N Engl J Med. 2020;382:e89.
    >> Share

  795. GRUBER J, Sommers BD
    Paying for Medicaid - State Budgets and the Case for Expansion in the Time of Coronavirus.
    N Engl J Med. 2020;382:2280-2282.
    >> Share

  796. WOLOSHIN S, Patel N, Kesselheim AS
    False Negative Tests for SARS-CoV-2 Infection - Challenges and Implications.
    N Engl J Med. 2020 Jun 5. doi: 10.1056/NEJMp2015897.
    >> Share

  797. WEINSTEIN MC, Freedberg KA, Hyle EP, Paltiel AD, et al
    Waiting for Certainty on Covid-19 Antibody Tests - At What Cost?
    N Engl J Med. 2020 Jun 5. doi: 10.1056/NEJMp2017739.
    >> Share

  798. CHAN AT, Brownstein JS
    Putting the Public Back in Public Health - Surveying Symptoms of Covid-19.
    N Engl J Med. 2020 Jun 5. doi: 10.1056/NEJMp2016259.
    >> Share

  799. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Diagnosis and Early Treatment of Covid-19.
    N Engl J Med. 2020;382:e103.
    >> Share

  800. MEHRA MR, Desai SS, Kuy S, Henry TD, et al
    Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.
    N Engl J Med. 2020 Jun 4. doi: 10.1056/NEJMc2021225.
    >> Share

  801. ARGENZIANO M, Fischkoff K, Smith CR
    Surgery Scheduling in a Crisis.
    N Engl J Med. 2020;382:e87.
    >> Share

  802. PARKS JM, Smith JC
    How to Discover Antiviral Drugs Quickly.
    N Engl J Med. 2020;382:2261-2264.
    >> Share

  803. ROURKE EJ
    Waiting.
    N Engl J Med. 2020;382:2184-2185.
    >> Share

  804. CASTELLETTI S
    A Shift on the Front Line.
    N Engl J Med. 2020;382:e83.
    >> Share

  805. FRAHER EP, Pittman P, Frogner BK, Spetz J, et al
    Ensuring and Sustaining a Pandemic Workforce.
    N Engl J Med. 2020;382:2181-2183.
    >> Share

  806. COHEN MS
    Hydroxychloroquine for the Prevention of Covid-19 - Searching for Evidence.
    N Engl J Med. 2020 Jun 3. doi: 10.1056/NEJMe2020388.
    >> Share

  807. KLOMPAS M, Morris CA, Shenoy ES
    Universal Masking in the Covid-19 Era.
    N Engl J Med. 2020 Jun 3. doi: 10.1056/NEJMc2020836.
    >> Share

  808. TU YP, Jennings R, Hart B, Cangelosi GA, et al
    Swabs Collected by Patients or Health Care Workers for SARS-CoV-2 Testing.
    N Engl J Med. 2020 Jun 3. doi: 10.1056/NEJMc2016321.
    >> Share

  809. BOULWARE DR, Pullen MF, Bangdiwala AS, Pastick KA, et al
    A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
    N Engl J Med. 2020 Jun 3. doi: 10.1056/NEJMoa2016638.
    >> Share

  810. RUBIN EJ
    Expression of Concern: Mehra MR et al. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.
    N Engl J Med. 2020 Jun 2. doi: 10.1056/NEJMe2020822.
    >> Share

    May 2020
  811. GANDHI M, Yokoe DS, Havlir DV
    Screening for Covid-19 in Skilled Nursing Facilities. Reply.
    N Engl J Med. 2020;382.
    >> Share

  812. HATFIELD KM, Reddy SC, Jernigan JA
    Screening for Covid-19 in Skilled Nursing Facilities. Reply.
    N Engl J Med. 2020;382.
    >> Share

  813. HUBER DH
    Screening for Covid-19 in Skilled Nursing Facilities.
    N Engl J Med. 2020;382.
    >> Share

  814. CALBO E, Masats U, Garau J
    Screening for Covid-19 in Skilled Nursing Facilities.
    N Engl J Med. 2020;382.
    >> Share

  815. KRSAK M, Henao-Martinez AF, Franco-Paredes C
    Screening for Covid-19 in Skilled Nursing Facilities.
    N Engl J Med. 2020;382.
    >> Share

  816. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: New Data on Remdesivir in Covid-19.
    N Engl J Med. 2020;382:e94.
    >> Share

  817. YAGER PH, Whalen KA, Cummings BM
    Repurposing a Pediatric ICU for Adults.
    N Engl J Med. 2020;382:e80.
    >> Share

  818. MARTY FM, Chen K, Verrill KA
    How to Obtain a Nasopharyngeal Swab Specimen.
    N Engl J Med. 2020;382:e76.
    >> Share

  819. SUTTON D, Fuchs K, D'Alton M, Goffman D, et al
    Universal Screening for SARS-CoV-2 in Women Admitted for Delivery.
    N Engl J Med. 2020;382:2163-2164.
    >> Share

  820. ROSENBAUM L
    Harnessing Our Humanity - How Washington's Health Care Workers Have Risen to the Pandemic Challenge.
    N Engl J Med. 2020;382:2069-2071.
    >> Share

  821. GOLDMAN JD, Lye DCB, Hui DS, Marks KM, et al
    Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
    N Engl J Med. 2020 May 27. doi: 10.1056/NEJMoa2015301.
    >> Share

  822. WERNER RM, Hoffman AK, Coe NB
    Long-Term Care Policy after Covid-19 - Solving the Nursing Home Crisis.
    N Engl J Med. 2020 May 27. doi: 10.1056/NEJMp2014811.
    >> Share

  823. PRICE-HAYWOOD EG, Burton J, Fort D, Seoane L, et al
    Hospitalization and Mortality among Black Patients and White Patients with Covid-19.
    N Engl J Med. 2020 May 27. doi: 10.1056/NEJMsa2011686.
    >> Share

  824. LAROCHELLE MR
    "Is It Safe for Me to Go to Work?" Risk Stratification for Workers during the Covid-19 Pandemic.
    N Engl J Med. 2020 May 26. doi: 10.1056/NEJMp2013413.
    >> Share

  825. HELMS J, Kremer S, Meziani F
    More on Neurologic Features in Severe SARS-CoV-2 Infection. Reply.
    N Engl J Med. 2020;382.
    >> Share

  826. SARIKAYA B
    More on Neurologic Features in Severe SARS-CoV-2 Infection.
    N Engl J Med. 2020;382.
    >> Share

  827. LARVIE M, Lev MH, Hess CP
    More on Neurologic Features in Severe SARS-CoV-2 Infection.
    N Engl J Med. 2020;382.
    >> Share

  828. BEIGEL JH, Tomashek KM, Dodd LE, Mehta AK, et al
    Remdesivir for the Treatment of Covid-19 - Preliminary Report.
    N Engl J Med. 2020 May 22. doi: 10.1056/NEJMoa2007764.
    >> Share

  829. HARIRI L, Hardin CC
    Covid-19, Angiogenesis, and ARDS Endotypes.
    N Engl J Med. 2020 May 21. doi: 10.1056/NEJMe2018629.
    >> Share

  830. ACKERMANN M, Verleden SE, Kuehnel M, Haverich A, et al
    Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.
    N Engl J Med. 2020 May 21. doi: 10.1056/NEJMoa2015432.
    >> Share

  831. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Capitalizing on Immune Responses to Covid-19.
    N Engl J Med. 2020;382:e93.
    >> Share

  832. MCMICHAEL TM, Currie DW, Clark S, Pogosjans S, et al
    Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington.
    N Engl J Med. 2020;382:2005-2011.
    >> Share

  833. PAGE KR, Venkataramani M, Beyrer C, Polk S, et al
    Undocumented U.S. Immigrants and Covid-19.
    N Engl J Med. 2020;382:e62.
    >> Share

  834. MCANULTY JM, Ward K
    Suppressing the Epidemic in New South Wales.
    N Engl J Med. 2020;382:e74.
    >> Share

  835. ZEIDEL ML, Kirk C, Linville-Engler B
    Opening Up New Supply Chains.
    N Engl J Med. 2020;382:e73.
    >> Share

  836. ANFINRUD P, Stadnytskyi V, Bax CE, Bax A, et al
    Visualizing Speech-Generated Oral Fluid Droplets with Laser Light Scattering.
    N Engl J Med. 2020;382:2061-2063.
    >> Share

  837. KOVEN S
    They Call Us and We Go.
    N Engl J Med. 2020;382:1978-1979.
    >> Share

  838. TRUOG RD, Mitchell C, Daley GQ
    The Toughest Triage - Allocating Ventilators in a Pandemic.
    N Engl J Med. 2020;382:1973-1975.
    >> Share

  839. ORTEGA R, Gonzalez M, Nozari A, Canelli R, et al
    Personal Protective Equipment and Covid-19.
    N Engl J Med. 2020 May 19. doi: 10.1056/NEJMvcm2014809.
    >> Share

  840. SOLOMON MZ, Wynia MK, Gostin LO
    Covid-19 Crisis Triage - Optimizing Health Outcomes and Disability Rights.
    N Engl J Med. 2020 May 19. doi: 10.1056/NEJMp2008300.
    >> Share

  841. SOLOMON MD, McNulty EJ, Rana JS, Leong TK, et al
    The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction.
    N Engl J Med. 2020 May 19. doi: 10.1056/NEJMc2015630.
    >> Share

  842. VADUGANATHAN M, Solomon SD
    Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19. Reply.
    N Engl J Med. 2020;382.
    >> Share

  843. BIRNBAUM RA
    Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.
    N Engl J Med. 2020;382.
    >> Share

  844. HAUG G, Eapen MS, Sohal SS
    Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.
    N Engl J Med. 2020;382.
    >> Share

  845. LUBEL J, Garg M
    Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.
    N Engl J Med. 2020;382.
    >> Share

  846. HOLMDAHL I, Buckee C
    Wrong but Useful - What Covid-19 Epidemiologic Models Can and Cannot Tell Us.
    N Engl J Med. 2020 May 15. doi: 10.1056/NEJMp2016822.
    >> Share

  847. BERLIN DA, Gulick RM, Martinez FJ
    Severe Covid-19.
    N Engl J Med. 2020 May 15. doi: 10.1056/NEJMcp2009575.
    >> Share

  848. GREIN J, Myers RP, Brainard D
    Compassionate Use of Remdesivir in Covid-19. Reply.
    N Engl J Med. 2020;382.
    >> Share

  849. WU J, Wu B, Lai T
    Compassionate Use of Remdesivir in Covid-19.
    N Engl J Med. 2020;382.
    >> Share

  850. HOFFMANN C
    Compassionate Use of Remdesivir in Covid-19.
    N Engl J Med. 2020;382.
    >> Share

  851. FATKENHEUER G, Lundgren J
    Compassionate Use of Remdesivir in Covid-19.
    N Engl J Med. 2020;382.
    >> Share

  852. BONOVAS S, Piovani D
    Compassionate Use of Remdesivir in Covid-19.
    N Engl J Med. 2020;382.
    >> Share

  853. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Finding Reliable Information about Covid-19.
    N Engl J Med. 2020;382:e81.
    >> Share

  854. JUDSON SD, van Doremalen N, Munster VJ
    Stability and Viability of SARS-CoV-2. Reply.
    N Engl J Med. 2020;382:1965-1966.
    >> Share

  855. PETTI S
    Stability and Viability of SARS-CoV-2.
    N Engl J Med. 2020;382:1964-1965.
    >> Share

  856. HELMERS A
    Stability and Viability of SARS-CoV-2.
    N Engl J Med. 2020;382:1964.
    >> Share

  857. LESHO E, Laguio-Vila M, Walsh E
    Stability and Viability of SARS-CoV-2.
    N Engl J Med. 2020;382:1963-1964.
    >> Share

  858. SCHWARTZ KL, Kim J, Garber G
    Stability and Viability of SARS-CoV-2.
    N Engl J Med. 2020;382:1963.
    >> Share

  859. RUBENS JH, Karakousis PC, Jain SK
    Stability and Viability of SARS-CoV-2.
    N Engl J Med. 2020;382:1962-1963.
    >> Share

  860. HICK JL, Biddinger PD
    Novel Coronavirus and Old Lessons - Preparing the Health System for the Pandemic.
    N Engl J Med. 2020;382:e55.
    >> Share

  861. HALFMANN PJ, Hatta M, Chiba S, Maemura T, et al
    Transmission of SARS-CoV-2 in Domestic Cats.
    N Engl J Med. 2020 May 13. doi: 10.1056/NEJMc2013400.
    >> Share

  862. SISE ME, Baggett MV, Shepard JO, Stevens JS, et al
    Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury.
    N Engl J Med. 2020 May 13. doi: 10.1056/NEJMcpc2002418.
    >> Share

  863. PUELLES VG, Lutgehetmann M, Lindenmeyer MT, Sperhake JP, et al
    Multiorgan and Renal Tropism of SARS-CoV-2.
    N Engl J Med. 2020 May 13. doi: 10.1056/NEJMc2011400.
    >> Share

  864. KANSAGRA AP, Goyal MS, Hamilton S, Albers GW, et al
    Collateral Effect of Covid-19 on Stroke Evaluation in the United States.
    N Engl J Med. 2020 May 8. doi: 10.1056/NEJMc2014816.
    >> Share

  865. CHUNG SC, Providencia R, Sofat R
    Association between Angiotensin Blockade and Incidence of Influenza in the United Kingdom.
    N Engl J Med. 2020 May 8. doi: 10.1056/NEJMc2005396.
    >> Share

  866. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Studying Potential Covid-19 Therapies.
    N Engl J Med. 2020;382:e72.
    >> Share

  867. RUBIN EJ, Harrington DP, Hogan JW, Gatsonis C, et al
    The Urgency of Care during the Covid-19 Pandemic - Learning as We Go.
    N Engl J Med. 2020 May 7. doi: 10.1056/NEJMe2015903.
    >> Share

  868. GELERIS J, Sun Y, Platt J, Zucker J, et al
    Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19.
    N Engl J Med. 2020 May 7. doi: 10.1056/NEJMoa2012410.
    >> Share

  869. PETERS AW, Chawla KS, Turnbull ZA
    Transforming ORs into ICUs.
    N Engl J Med. 2020;382:e52.
    >> Share

  870. HAUG C
    French Pandemic Resistance.
    N Engl J Med. 2020;382:e51.
    >> Share

  871. SONG JY, Yun JG, Noh JY, Cheong HJ, et al
    Covid-19 in South Korea - Challenges of Subclinical Manifestations.
    N Engl J Med. 2020;382:1858-1859.
    >> Share

  872. GUAN WJ, Zhong NS
    Clinical Characteristics of Covid-19 in China. Reply.
    N Engl J Med. 2020;382:1861-1862.
    >> Share

  873. HENRY BM, Vikse J
    Clinical Characteristics of Covid-19 in China.
    N Engl J Med. 2020;382:1860-1861.
    >> Share

  874. ROLF JD
    Clinical Characteristics of Covid-19 in China.
    N Engl J Med. 2020;382:1860.
    >> Share

  875. CHEN ATC, Coura-Filho GB, Rehder MHH
    Clinical Characteristics of Covid-19 in China.
    N Engl J Med. 2020;382:1860.
    >> Share

  876. ZAVASCKI AP, Falci DR
    Clinical Characteristics of Covid-19 in China.
    N Engl J Med. 2020;382:1859.
    >> Share

  877. SWERDLOW DL, Finelli L, Lipsitch M
    Epidemiology of Covid-19. Reply.
    N Engl J Med. 2020;382:1869-1870.
    >> Share

  878. ZHANG X
    Epidemiology of Covid-19.
    N Engl J Med. 2020;382:1869.
    >> Share

  879. KRAMER DB, Lo B, Dickert NW
    CPR in the Covid-19 Era - An Ethical Framework.
    N Engl J Med. 2020 May 6. doi: 10.1056/NEJMp2010758.
    >> Share

  880. CREEL-BULOS C, Hockstein M, Amin N, Melhem S, et al
    Acute Cor Pulmonale in Critically Ill Patients with Covid-19.
    N Engl J Med. 2020 May 6. doi: 10.1056/NEJMc2010459.
    >> Share

  881. CHOWKWANYUN M, Reed AL Jr
    Racial Health Disparities and Covid-19 - Caution and Context.
    N Engl J Med. 2020 May 6. doi: 10.1056/NEJMp2012910.
    >> Share

  882. CAO B, Zhang D, Wang C
    A Trial of Lopinavir-Ritonavir in Covid-19. Reply.
    N Engl J Med. 2020;382.
    >> Share

  883. CARMONA-BAYONAS A, Jimenez-Fonseca P, Castanon E
    A Trial of Lopinavir-Ritonavir in Covid-19.
    N Engl J Med. 2020;382.
    >> Share

  884. CORRAO S, Natoli G, Cacopardo B
    A Trial of Lopinavir-Ritonavir in Covid-19.
    N Engl J Med. 2020;382.
    >> Share

  885. HAVLICHEK D JR
    A Trial of Lopinavir-Ritonavir in Covid-19.
    N Engl J Med. 2020;382.
    >> Share

  886. KUNZ KM
    A Trial of Lopinavir-Ritonavir in Covid-19.
    N Engl J Med. 2020;382.
    >> Share

  887. DALERBA P, Levin B, Thompson JL
    A Trial of Lopinavir-Ritonavir in Covid-19.
    N Engl J Med. 2020;382.
    >> Share

  888. BOWLES L, Platton S, Yartey N, Dave M, et al
    Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.
    N Engl J Med. 2020 May 5. doi: 10.1056/NEJMc2013656.
    >> Share

  889. FAGIUOLI S, Lorini FL, Remuzzi G
    Adaptations and Lessons in the Province of Bergamo.
    N Engl J Med. 2020 May 5. doi: 10.1056/NEJMc2011599.
    >> Share

  890. PARRI N, Lenge M, Buonsenso D
    Children with Covid-19 in Pediatric Emergency Departments in Italy.
    N Engl J Med. 2020 May 1. doi: 10.1056/NEJMc2007617.
    >> Share

  891. CHU HY, Englund JA, Starita LM, Famulare M, et al
    Early Detection of Covid-19 through a Citywide Pandemic Surveillance Platform.
    N Engl J Med. 2020 May 1. doi: 10.1056/NEJMc2008646.
    >> Share

  892. REYNOLDS HR, Adhikari S, Pulgarin C, Troxel AB, et al
    Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19.
    N Engl J Med. 2020 May 1. doi: 10.1056/NEJMoa2008975.
    >> Share

  893. MANCIA G, Rea F, Ludergnani M, Apolone G, et al
    Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19.
    N Engl J Med. 2020 May 1. doi: 10.1056/NEJMoa2006923.
    >> Share

  894. MEHRA MR, Desai SS, Kuy S, Henry TD, et al
    Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.
    N Engl J Med. 2020 May 1. doi: 10.1056/NEJMoa2007621.
    >> Share

  895. JARCHO JA, Ingelfinger JR, Hamel MB, D'Agostino RB Sr, et al
    Inhibitors of the Renin-Angiotensin-Aldosterone System and Covid-19.
    N Engl J Med. 2020 May 1. doi: 10.1056/NEJMe2012924.
    >> Share

    April 2020
  896. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Loosening Covid-19 Restrictions.
    N Engl J Med. 2020;382:e67.
    >> Share

  897. ARTENSTEIN AW
    In Pursuit of PPE.
    N Engl J Med. 2020;382:e46.
    >> Share

  898. LEUNG GM, Cowling BJ, Wu JT
    From a Sprint to a Marathon in Hong Kong.
    N Engl J Med. 2020;382:e45.
    >> Share

  899. SINGER AJ, Morley EJ, Henry MC
    Staying Ahead of the Wave.
    N Engl J Med. 2020;382:e44.
    >> Share

  900. ROSE C
    Am I Part of the Cure or Am I Part of the Disease? Keeping Coronavirus Out When a Doctor Comes Home.
    N Engl J Med. 2020;382:1684-1685.
    >> Share

  901. HABERMAN R, Axelrad J, Chen A, Castillo R, et al
    Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York.
    N Engl J Med. 2020 Apr 29. doi: 10.1056/NEJMc2009567.
    >> Share

  902. BALDI E, Sechi GM, Mare C, Canevari F, et al
    Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy.
    N Engl J Med. 2020 Apr 29. doi: 10.1056/NEJMc2010418.
    >> Share

  903. ZAGURY-ORLY I, Schwartzstein RM
    Covid-19 - A Reminder to Reason.
    N Engl J Med. 2020 Apr 28. doi: 10.1056/NEJMp2009405.
    >> Share

  904. OXLEY TJ, Mocco J, Majidi S, Kellner CP, et al
    Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young.
    N Engl J Med. 2020 Apr 28. doi: 10.1056/NEJMc2009787.
    >> Share

  905. PERSAD G, Phillips J, Emanuel EJ
    Allocating Medical Resources in the Time of Covid-19. Reply.
    N Engl J Med. 2020;382.
    >> Share

  906. HYDER AA
    Allocating Medical Resources in the Time of Covid-19.
    N Engl J Med. 2020;382.
    >> Share

  907. FIRTH P, Eyal N
    Allocating Medical Resources in the Time of Covid-19.
    N Engl J Med. 2020;382.
    >> Share

  908. LIDDELL K, Martin S, Palmer S
    Allocating Medical Resources in the Time of Covid-19.
    N Engl J Med. 2020;382.
    >> Share

  909. BROWN MJ, Goodwin J
    Allocating Medical Resources in the Time of Covid-19.
    N Engl J Med. 2020;382.
    >> Share

  910. PRAMESH CS, Badwe RA
    Cancer Management in India during Covid-19.
    N Engl J Med. 2020 Apr 28. doi: 10.1056/NEJMc2011595.
    >> Share

  911. DE FILIPPO O, D'Ascenzo F, Angelini F, Bocchino PP, et al
    Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy.
    N Engl J Med. 2020 Apr 28. doi: 10.1056/NEJMc2009166.
    >> Share

  912. AKALIN E, Azzi Y, Bartash R, Seethamraju H, et al
    Covid-19 and Kidney Transplantation.
    N Engl J Med. 2020 Apr 24. doi: 10.1056/NEJMc2011117.
    >> Share

  913. GANDHI RT, Lynch JB, Del Rio C
    Mild or Moderate Covid-19.
    N Engl J Med. 2020 Apr 24. doi: 10.1056/NEJMcp2009249.
    >> Share

  914. GANDHI M, Yokoe DS, Havlir DV
    Asymptomatic Transmission, the Achilles' Heel of Current Strategies to Control Covid-19.
    N Engl J Med. 2020 Apr 24. doi: 10.1056/NEJMe2009758.
    >> Share

  915. ARONS MM, Hatfield KM, Reddy SC, Kimball A, et al
    Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.
    N Engl J Med. 2020 Apr 24. doi: 10.1056/NEJMoa2008457.
    >> Share

  916. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Approaches to Covid-19 Vaccines and Antivirals.
    N Engl J Med. 2020;382:e58.
    >> Share

  917. UYEKI TM, Holshue ML, Diaz G
    First Case of Covid-19 in the United States. Reply.
    N Engl J Med. 2020;382.
    >> Share

  918. REN C, Chen H, Chen HZ
    First Case of Covid-19 in the United States.
    N Engl J Med. 2020;382.
    >> Share

  919. LINK A, Hold G
    First Case of Covid-19 in the United States.
    N Engl J Med. 2020;382.
    >> Share

  920. WEN Q, Yang J, Luo T
    First Case of Covid-19 in the United States.
    N Engl J Med. 2020;382.
    >> Share

  921. ZHANG YM
    First Case of Covid-19 in the United States.
    N Engl J Med. 2020;382.
    >> Share

  922. TSUNG K
    First Case of Covid-19 in the United States.
    N Engl J Med. 2020;382.
    >> Share

  923. WENG L, Jiao Y, Li Y
    First Case of Covid-19 in the United States.
    N Engl J Med. 2020;382.
    >> Share

  924. CORONADO MUNOZ A, Nawaratne U, McMann D, Ellsworth M, et al
    Late-Onset Neonatal Sepsis in a Patient with Covid-19.
    N Engl J Med. 2020 Apr 22. doi: 10.1056/NEJMc2010614.
    >> Share

  925. TOSCANO G, Palmerini F, Ravaglia S, Ruiz L, et al
    Guillain-Barre Syndrome Associated with SARS-CoV-2.
    N Engl J Med. 2020 Apr 17. doi: 10.1056/NEJMc2009191.
    >> Share

  926. BANGALORE S, Sharma A, Slotwiner A, Yatskar L, et al
    ST-Segment Elevation in Patients with Covid-19 - A Case Series.
    N Engl J Med. 2020 Apr 17. doi: 10.1056/NEJMc2009020.
    >> Share

  927. KOFF WC, Williams MA
    Covid-19 and Immunity in Aging Populations - A New Research Agenda.
    N Engl J Med. 2020 Apr 17. doi: 10.1056/NEJMp2006761.
    >> Share

  928. GOYAL P, Choi JJ, Pinheiro LC, Schenck EJ, et al
    Clinical Characteristics of Covid-19 in New York City.
    N Engl J Med. 2020 Apr 17. doi: 10.1056/NEJMc2010419.
    >> Share

  929. CHEN L, Li Q, Zheng D, Jiang H, et al
    Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China.
    N Engl J Med. 2020 Apr 17. doi: 10.1056/NEJMc2009226.
    >> Share

  930. ROSENBAUM L
    The Untold Toll - The Pandemic's Effects on Patients without Covid-19.
    N Engl J Med. 2020 Apr 17. doi: 10.1056/NEJMms2009984.
    >> Share

  931. EL-SADR WM, Justman J
    Africa in the Path of Covid-19.
    N Engl J Med. 2020 Apr 17. doi: 10.1056/NEJMp2008193.
    >> Share

  932. KING JS
    Covid-19 and the Need for Health Care Reform.
    N Engl J Med. 2020 Apr 17. doi: 10.1056/NEJMp2000821.
    >> Share

  933. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Caring for Patients with Covid-19.
    N Engl J Med. 2020;382:e50.
    >> Share

  934. BRANDT AM, Botelho A
    Not a Perfect Storm - Covid-19 and the Importance of Language.
    N Engl J Med. 2020;382:1493-1495.
    >> Share

  935. MESELSON M
    Droplets and Aerosols in the Transmission of SARS-CoV-2.
    N Engl J Med. 2020 Apr 15. doi: 10.1056/NEJMc2009324.
    >> Share

  936. ZHAN M, Qin Y, Xue X, Zhu S, et al
    Death from Covid-19 of 23 Health Care Workers in China.
    N Engl J Med. 2020 Apr 15. doi: 10.1056/NEJMc2005696.
    >> Share

  937. ZULFIQAR AA, Lorenzo-Villalba N, Hassler P, Andres E, et al
    Immune Thrombocytopenic Purpura in a Patient with Covid-19.
    N Engl J Med. 2020 Apr 15. doi: 10.1056/NEJMc2010472.
    >> Share

  938. HELMS J, Kremer S, Merdji H, Clere-Jehl R, et al
    Neurologic Features in Severe SARS-CoV-2 Infection.
    N Engl J Med. 2020 Apr 15. doi: 10.1056/NEJMc2008597.
    >> Share

  939. ROME BN, Avorn J
    Drug Evaluation during the Covid-19 Pandemic.
    N Engl J Med. 2020 Apr 14. doi: 10.1056/NEJMp2009457.
    >> Share

  940. WAKAM GK, Montgomery JR, Biesterveld BE, Brown CS, et al
    Not Dying Alone - Modern Compassionate Care in the Covid-19 Pandemic.
    N Engl J Med. 2020 Apr 14. doi: 10.1056/NEJMp2007781.
    >> Share

  941. GUDBJARTSSON DF, Helgason A, Jonsson H, Magnusson OT, et al
    Spread of SARS-CoV-2 in the Icelandic Population.
    N Engl J Med. 2020 Apr 14. doi: 10.1056/NEJMoa2006100.
    >> Share

  942. GREIN J, Ohmagari N, Shin D, Diaz G, et al
    Compassionate Use of Remdesivir for Patients with Severe Covid-19.
    N Engl J Med. 2020 Apr 10. doi: 10.1056/NEJMoa2007016.
    >> Share

  943. STUDDERT DM, Hall MA
    Disease Control, Civil Liberties, and Mass Testing - Calibrating Restrictions during the Covid-19 Pandemic.
    N Engl J Med. 2020 Apr 9. doi: 10.1056/NEJMp2007637.
    >> Share

  944. BAYEFSKY MJ, Bartz D, Watson KL
    Abortion during the Covid-19 Pandemic - Ensuring Access to an Essential Health Service.
    N Engl J Med. 2020 Apr 9. doi: 10.1056/NEJMp2008006.
    >> Share

  945. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Emerging Tools in the Fight against Covid-19.
    N Engl J Med. 2020;382:e39.
    >> Share

  946. ZHANG Y, Xiao M, Zhang S, Xia P, et al
    Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.
    N Engl J Med. 2020 Apr 8. doi: 10.1056/NEJMc2007575.
    >> Share

  947. GALLAGHER TH, Schleyer AM
    "We Signed Up for This!" - Student and Trainee Responses to the Covid-19 Pandemic.
    N Engl J Med. 2020 Apr 8. doi: 10.1056/NEJMp2005234.
    >> Share

  948. LEWIS MA
    Between Scylla and Charybdis - Oncologic Decision Making in the Time of Covid-19.
    N Engl J Med. 2020 Apr 7. doi: 10.1056/NEJMp2006588.
    >> Share

  949. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Lessons from Covid-19 Hotspots.
    N Engl J Med. 2020;382:e35.
    >> Share

  950. AKIYAMA MJ, Spaulding AC, Rich JD
    Flattening the Curve for Incarcerated Populations - Covid-19 in Jails and Prisons.
    N Engl J Med. 2020 Apr 2. doi: 10.1056/NEJMp2005687.
    >> Share

  951. KEESARA S, Jonas A, Schulman K
    Covid-19 and Health Care's Digital Revolution.
    N Engl J Med. 2020 Apr 2. doi: 10.1056/NEJMp2005835.
    >> Share

  952. HAFFAJEE RL, Mello MM
    Thinking Globally, Acting Locally - The U.S. Response to Covid-19.
    N Engl J Med. 2020 Apr 2. doi: 10.1056/NEJMp2006740.
    >> Share

  953. KLOMPAS M, Morris CA, Sinclair J, Pearson M, et al
    Universal Masking in Hospitals in the Covid-19 Era.
    N Engl J Med. 2020 Apr 1. doi: 10.1056/NEJMp2006372.
    >> Share

  954. IQBAL SN, Overcash R, Mokhtari N, Saeed H, et al
    An Uncomplicated Delivery in a Patient with Covid-19 in the United States.
    N Engl J Med. 2020 Apr 1. doi: 10.1056/NEJMc2007605.
    >> Share

    March 2020
  955. VADUGANATHAN M, Vardeny O, Michel T, McMurray JJV, et al
    Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.
    N Engl J Med. 2020 Mar 30. doi: 10.1056/NEJMsr2005760.
    >> Share

  956. DUNN CG, Kenney E, Fleischhacker SE, Bleich SN, et al
    Feeding Low-Income Children during the Covid-19 Pandemic.
    N Engl J Med. 2020 Mar 30. doi: 10.1056/NEJMp2005638.
    >> Share

  957. BHATRAJU PK, Ghassemieh BJ, Nichols M, Kim R, et al
    Covid-19 in Critically Ill Patients in the Seattle Region - Case Series.
    N Engl J Med. 2020 Mar 30. doi: 10.1056/NEJMoa2004500.
    >> Share

  958. LURIE N, Saville M, Hatchett R, Halton J, et al
    Developing Covid-19 Vaccines at Pandemic Speed.
    N Engl J Med. 2020 Mar 30. doi: 10.1056/NEJMp2005630.
    >> Share

  959. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Practical Measures to Help Prevent Covid-19.
    N Engl J Med. 2020;382:e32.
    >> Share

  960. RANNEY ML, Griffeth V, Jha AK
    Critical Supply Shortages - The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic.
    N Engl J Med. 2020 Mar 25. doi: 10.1056/NEJMp2006141.
    >> Share

  961. EMANUEL EJ, Persad G, Upshur R, Thome B, et al
    Fair Allocation of Scarce Medical Resources in the Time of Covid-19.
    N Engl J Med. 2020 Mar 23. doi: 10.1056/NEJMsb2005114.
    >> Share

  962. HUNTER DJ
    Covid-19 and the Stiff Upper Lip - The Pandemic Response in the United Kingdom.
    N Engl J Med. 2020 Mar 20. doi: 10.1056/NEJMp2005755.
    >> Share

  963. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: New Research on Possible Treatments for Covid-19.
    N Engl J Med. 2020;382:e30.
    >> Share

  964. CAO B, Wang Y, Wen D, Liu W, et al
    A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
    N Engl J Med. 2020 Mar 18. doi: 10.1056/NEJMoa2001282.
    >> Share

  965. BADEN LR, Rubin EJ
    Covid-19 - The Search for Effective Therapy.
    N Engl J Med. 2020 Mar 18. doi: 10.1056/NEJMe2005477.
    >> Share

  966. PARMET WE, Sinha MS
    Covid-19 - The Law and Limits of Quarantine.
    N Engl J Med. 2020 Mar 18. doi: 10.1056/NEJMp2004211.
    >> Share

  967. ROSENBAUM L
    Facing Covid-19 in Italy - Ethics, Logistics, and Therapeutics on the Epidemic's Front Line.
    N Engl J Med. 2020 Mar 18. doi: 10.1056/NEJMp2005492.
    >> Share

  968. LU X, Zhang L, Du H, Zhang J, et al
    SARS-CoV-2 Infection in Children.
    N Engl J Med. 2020 Mar 18. doi: 10.1056/NEJMc2005073.
    >> Share

  969. VAN DOREMALEN N, Bushmaker T, Morris DH, Holbrook MG, et al
    Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.
    N Engl J Med. 2020 Mar 17. doi: 10.1056/NEJMc2004973.
    >> Share

  970. JONES DS
    History in a Crisis - Lessons for Covid-19.
    N Engl J Med. 2020 Mar 12. doi: 10.1056/NEJMp2004361.
    >> Share

  971. NG OT, Marimuthu K, Chia PY, Koh V, et al
    SARS-CoV-2 Infection among Travelers Returning from Wuhan, China.
    N Engl J Med. 2020 Mar 12. doi: 10.1056/NEJMc2003100.
    >> Share

  972. LIU W, Zhang Q, Chen J, Xiang R, et al
    Detection of Covid-19 in Children in Early January 2020 in Wuhan, China.
    N Engl J Med. 2020 Mar 12. doi: 10.1056/NEJMc2003717.
    >> Share

  973. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Making Decisions about Covid-19 Testing and Treatment for Your Patients.
    N Engl J Med. 2020;382:e25.
    >> Share

  974. HOLLANDER JE, Carr BG
    Virtually Perfect? Telemedicine for Covid-19.
    N Engl J Med. 2020 Mar 11. doi: 10.1056/NEJMp2003539.
    >> Share

  975. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: What Clinicians Need to Know in Diagnosing and Treating Covid-19.
    N Engl J Med. 2020;382:e19.
    >> Share

    February 2020
  976. GUAN WJ, Ni ZY, Hu Y, Liang WH, et al
    Clinical Characteristics of Coronavirus Disease 2019 in China.
    N Engl J Med. 2020 Feb 28. doi: 10.1056/NEJMoa2002032.
    >> Share

  977. GATES B
    Responding to Covid-19 - A Once-in-a-Century Pandemic?
    N Engl J Med. 2020 Feb 28. doi: 10.1056/NEJMp2003762.
    >> Share

  978. FAUCI AS, Lane HC, Redfield RR
    Covid-19 - Navigating the Uncharted.
    N Engl J Med. 2020 Feb 28. doi: 10.1056/NEJMe2002387.
    >> Share

  979. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Preparing for the Spread of Covid-19.
    N Engl J Med. 2020;382:e18.
    >> Share

  980. ZOU L, Ruan F, Huang M, Liang L, et al
    SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients.
    N Engl J Med. 2020 Feb 19. doi: 10.1056/NEJMc2001737.
    >> Share

  981. LIPSITCH M, Swerdlow DL, Finelli L
    Defining the Epidemiology of Covid-19 - Studies Needed.
    N Engl J Med. 2020 Feb 19. doi: 10.1056/NEJMp2002125.
    >> Share

  982. HOEHL S, Berger A, Kortenbusch M, Cinatl J, et al
    Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China.
    N Engl J Med. 2020 Feb 18. doi: 10.1056/NEJMc2001899.
    >> Share

  983. LIU YC, Liao CH, Chang CF, Chou CC, et al
    A Locally Transmitted Case of SARS-CoV-2 Infection in Taiwan.
    N Engl J Med. 2020 Feb 12. doi: 10.1056/NEJMc2001573.
    >> Share

    January 2020
  984. HOLSHUE ML, DeBolt C, Lindquist S, Lofy KH, et al
    First Case of 2019 Novel Coronavirus in the United States.
    N Engl J Med. 2020 Jan 31. doi: 10.1056/NEJMoa2001191.
    >> Share

  985. ROTHE C, Schunk M, Sothmann P, Bretzel G, et al
    Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.
    N Engl J Med. 2020 Jan 30. doi: 10.1056/NEJMc2001468.
    >> Share

  986. LI Q, Guan X, Wu P, Wang X, et al
    Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.
    N Engl J Med. 2020 Jan 29. doi: 10.1056/NEJMoa2001316.
    >> Share

  987. RUBIN EJ, Baden LR, Morrissey S, Campion EW, et al
    Medical Journals and the 2019-nCoV Outbreak.
    N Engl J Med. 2020 Jan 27. doi: 10.1056/NEJMe2001329.
    >> Share

  988. ZHU N, Zhang D, Wang W, Li X, et al
    A Novel Coronavirus from Patients with Pneumonia in China, 2019.
    N Engl J Med. 2020 Jan 24. doi: 10.1056/NEJMoa2001017.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016